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 Abstract 
 
Antimicrobial peptides produced by lactic acid bacteria (LAB) are extensively studied, but little is 
know about their three-dimensional structures. Solution structures of these peptides will be useful to 
gain information about their mode of action, which again is important for further use of these 
substances in industry and medicine. Curvacin A is an antimicrobial peptide that belongs to the 
family of pediocin-like bacteriocins. 
 
Curvacin A was produced from its natural LAB producer, Lactobacillus curvatus LTH1174, and 
purified by ion-exchange- and reverse phase chromatography. Circular Dichroism-experiments 
revealed that curvacin A was unstructured in water, but became structured upon interactions with 
membrane-mimicking environments such as dodecyl phosphocholin (DPC)-micelles. 
 
The three-dimensional structure of curvacin A in DPC-micelles has been elucidated by the use of 
nuclear magnetic resonance (NMR)-spectroscopy. Curvacin A was shown to contain three regions: 
an N-terminal S-shaped β-sheet like domain (residues 2-15), a central polar helix (residues 19-24) 
and an amphiphilic C-terminal helix (residues 29-39). The C-terminal tail consists of only two 
residues (G40 and M41) and seems to be unstructured. There was a hinge between these regions, 
enabling the regions to move relative to each other.  
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1 Introduction 
 
1.1 Antimicrobial peptides produced by lactic acid bacteria 
 
Historically, fermentation of food and beverage is an ancient tradition where the intrinsic properties 
of lactic acid bacteria (LAB) are utilized. Fermentation is a way of preserving food from harmful 
degradation by  bacteria and other food-borne pathogens [1]. The protective power of LABs has 
been ascribed to the presence of their main end product, lactate [2]. Lactate creates an acidic 
environment that effectively prevents growth of almost all potential spoilage microorganisms [2, 3].  
 
In recent years, the focus of attention has moved to antimicrobial peptides (AMPs) secreted by LABs 
that kill other similar bacterial strains. Specifically, ribosomally synthesized membrane-
permeabilizing AMPs, termed bacteriocins, produced by a wide variety of LABs have been of 
interest. These peptides are usually cationic, small (< 50-60 residues) and contain a putative 
amphiphilic or hydrophobic region [4].  
 
In search of possible active agents to be used in areas such as pharmaceutical industry and 
agriculture, biologically naturally occurring substances that might prove effective against different 
pathogens are of interest. As the flux of antibiotic-resistant pathogens increases, it has become 
paramount to find new sources of future effective drugs and food-preservatives to replace soon-to-be 
ineffective antibiotics [5]. Bacteriocins show promising features in this respect [3, 6, 7]. Many are 
produced naturally in fermented food, and have been implemented in inhibiting numerous food 
spoilage organisms [4, 8].  
 
1.2 Classification of bacteriocins produced by LAB: 
 
Peptide bacteriocins produced by LAB have been classified into two groups based on their primary 
structure [9] (Figure 1.2.1). 
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Figure 1.2.1: Classification of peptide bacteriocins produced by LAB. The LAB peptide bacteriocins are divided into two 
groups, class I and class II. Class II is further divided into three subgroups. 
 
The lantibiotics (class I) are post-translationally modified peptides. They all contain the modified 
residues lanthionine and/or β-methyllanthionine [4, 10, 11]. In addition, other modified residues 
such as D-alanine and dehydrated amino acids may be present [12, 13].  
 
The unmodified peptides in class II are further divided into three subclasses [3]. The listeria active 
subclass IIa bacteriocins kill cells by permeabilizing the cell membrane [14]. They are often termed 
pediocin-like bacteriocins due to their resemblance to pediocin PA-1 (one of the first AMPs in this 
subclass to be identified and characterized), and this term is used here [15]. The two-peptide 
bacteriocins (subclass IIb) consist of two different peptides. Both peptides must be present for the 
bacteriocin to display antimicrobial activity [16]. Subclass IIc consists of a diverse group of non-
pediocin-like one-peptide bacteriocins [16]. 
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1.3 Biosynthesis and secretion of bacteriocins: 
 
Production of bacteriocins requires at least four genes [17-22]. These genes are found in close 
proximity, usually organized in one or two operons. One gene encodes the peptide precursor 
(prepeptides), a second the immunity protein that renders the bacteria immune to the bacteriocins it 
produces. A third gene encodes a membrane-associated ABC transporter: The prepeptides are 
transported across the membrane concomitantly with cleavage of a leader sequence. Finally, a fourth 
gene encodes an accessory protein necessary for secretion of the bacteriocin. Figure 1.3.1 
schematically illustrates biosynthesis and secretion of bacteriocins. 
 
ABC-transporter
Immunity 
protein
HK
RR
P
RR
C
ytoplasm
ic side
E
xtra cellular side
ADP                        ATPATP                        ADP
Gene activation
Activation of genes encoding 
bacteriocin, immunity protein, 
secretory apparatus and regulatory 
proteins
= Mature bacteriocin        
= Mature inducer peptide 
= Leader peptide              
= Pre-bacteriocin               
= Pre-inducer peptide 
Response 
regulator
Histidine kinase
P
RR
 
Figure 1.3.1 Illustration of biosynthesis and secretion of bacteriocins. A histidine kinase is activated by mature inducer 
peptide, and phosphorylates a response regulator. This response regulator binds to the DNA, and the genes indicated in 
the figure are activated. Pre-bacteriocin and pre-inducer peptide are transported across the membrane concomitantly with 
cleavage of a leader sequence. 
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The prepeptide contains an N-terminal leader sequence, which is cleaved off C-terminally of a 
double glycine motif. The 15 to 30 residues long leader sequence presumably facilitates interactions 
with the transporter and keeps the bacteriocin inactive until it is secreted from the cell [19-24]. 
 
Some bacteriocins (e.g curvacin A, sakacin P, carnobacteriocin B2 and enterocin A) are produced 
under regulation of a three-component signal transduction system, encoded by three additional genes 
[25, 26]. 
 
1.4 Group IIa bacteriocins: 
 
Peptide chains of the pediocin-like bacteriocins may roughly be divided into two regions based on 
their primary structure (Figure 1.4.1) [27, 28]. The N-terminal region contains the highly conserved 
Y-G-N-G-V/L, or “pediocin-box”, motif. The region is hydrophilic and cationic, and contains two 
cysteine residues linked by a disulfide bridge. The C-terminal region is less conserved and is 
hydrophilic or amphiphilic. 
 
Based on multiple sequence alignment of the C-terminal part, pediocin-like bacteriocins have been 
divided into three groups (Figure1.4.1). 
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1       1        10       20        30        40    References 
       .        .         .         .         .   
Enterocin A:        TTHSGKYYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGGAIPG--KC    [29]    
Divercin V41:     TKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIPG--KC    [30] 
 Divergicin M35:  TKYYGNGVYCNSKKCWVDWGTAQGCID--VVIGQLGGGIPGKGKC     [31] 
Coagulin:    KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGTHKC     [32] 
Pediocin PA-1:   KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC     [15, 20] 
Piscicocin CS526:    KYYGNGLSxNKKGxTVDWGTAIGIIGNNAAANxATGGAAGxNK?     [33] 
Sakacin P:    KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK     [34] 
Listeriocin 743A:   KSYGNGVHCNKKKCWVDWGSAISTIGNNSAANWATGGAAGWKS     [35] 
Mundticin:    KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWSK     [36] 
Mundticin KS:   KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS     [37] 
Piscicolin 126:   KYYGNGVSCNKNGCTVDWSKAIGIIGNNAAANLTTGGAAGWNKG    [38, 39] 
Sakacin 5X:    KYYGNGLSCNKSGCSVDWSKAISIIGNNAVANLTTGGAAGWKS     [40] 
Leucocin C:    KNYGNGVHCTKKGCSVDWGYAWTNIANNSVMNGLTGGNAGWHN     [41]  
2 
Leucocin A:    KYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW     [42] 
Mesentericin Y105:  KYYGNGVHCTKSGCSVNWGEAASAGIHRLANGGNGFW      [43] 
Lactococcin MMFII:  TSYGNGVHCNKSKCWIDVSELETYKAGTVSNPKDILW      [44] 
Sakacin G:    KYYGNGVSCNSHGCSVNWGQAWTCGVNHLANGGHGVC      [45] 
Plantaricin 423:   KYYGNGVTCGKHSCSVNWGQAFSCSVSHLANFGHGKC      [46]    
Plantaricin C19:   KYYGNGLSCSKKGCTVNWGQAFSCGVNRVATAGHGKx      [47] 
3  
Curvacin A:      ARSYGNGVYCNNKKCWVNRGEATQSIIGGMISGWASGLAGM     [48, 49] 
Carnobacteriocin BM1: AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH     [50] 
Enterocin P:      ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH       [51]  
Bacteriocin31:       ATYYGNGLYCNKQKCWVDWNKASREIGKIIVNGWVQHGPWAPR     [52] 
Carnobacteriocin B2:  VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP  [50] 
 
 
Figure 1.4.1: Multiple sequence alignment of pediocin-like subgroup IIa bacteriocins highlighting the YGNGV/L “pediocin box” motif (bold face) and conserved 
cysteine residues (bold face) in the N-terminal half, tryptophan residues (black boxes), and conserved residues in the C-terminal half of the peptides (yellow, blue, 
gray, green and red boxes). The C-terminal half is more diverse than the N-terminal half, and the classification of the peptides into three groups (indicated by 1, 2 and 
3 in the figure) is thus based on sequence similarities and differences in the C-terminal half of the peptides. There is a flexible hinge at the conserved Asp17 (green 
boxes) in peptides of group 1, and presumably also at Asn17/Asp17 (green boxes) in peptides of group 2 and 3. This hinge separates the b-sheet N-terminal domain 
and the hairpin-like C-terminal domain. Note that in numbering the residues (as indicated above in the sequence), residue number 2 before the well conserved 
YGNGV motif is in all cases referred to as residue 1, since this residue is the first residue in most -but not all – of the peptides. The PILEUP program of the Genetics 
Computer Group sequence analysis program package (Wisconsin Package Version 8.1, Genetic Computer Group) was used to set up the alignments [27] 
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1.4.1 Three-dimensional structure of the pediocin-like bacteriocins 
 
NMR-structures of four different pediocin-like bacteriocins have been reported so far; leucocin A 
(group 2; Figure 1.4.1) [53], carnobacteriocin B2 (group 3; Figure 1.4.1) [54],  sakacin P (group 1; 
Figure 1.4.1) [16] and a modified version of sakacin P where an additional disulfide bridge has been 
introduced [16].  
 
As all the peptides are unstructured in water, but become structured when introduced to a membrane-
mimicking environment [16, 43, 53-55], they have to be dissolved in a structure-inducing solvent in 
order for their structure to be analyzed. The peptides must be dissolved in a membrane-mimicking 
environment such as dodecyl phosphocholin (DPC) micelles or trifluoroethanol (TFE) to provide the 
right conditions for structuring of the peptides. TFE is known to induce helical structuring in 
proteins, possibly at the expense of β-sheet structures [56], and thus structures calculated from TFE-
dissolved peptides might show an unrealistically high content of α-helix. Even so, peptides can 
benefit from being dissolved in TFE as this stabilizes secondary-structure formation at the cost of 
hydrogen bonds between water and the peptide [56]. 
 
 Leucocin A was the first pediocin-like bacteriocin whose structure was elucidated [53]. The peptide, 
which belongs to group 2 (Figure 1.4.1), was shown to contain an antiparallel three-stranded β-sheet-
like structure from residue 2-16 and this was followed by an amphiphilic α-helix spanning residues 
17-31, and what appeared to be an unstructured C-terminal tail from residue 32 to 37. 
 
The group 1 pediocin-like bacteriocin sakacin P (Figure 1.4.1) and the mutated variant sakacin P 
[N24C+44C] were subsequently also shown to contain an N-terminal three-stranded β-sheet-like 
structure (from residue 1 to 17) followed by an amphiphilic α-helix between residue 18 and 33 [16]. 
Moreover, it was shown that the C-terminal tail (residues 34-43 for sakacin P and 34-44 for sakacin 
P [N24C+44C]) folds back on the amphiphilic helix, thus forming a hairpin-like structure (from 
residue 18 to 43/44), which is stabilized by a disulfide bridge (in sakacin P [N24C+44C] ) or by two 
tryptophan residues (in sakacin P) that position themselves in the membrane interface (see Figure 
1.4.2.1) [16, 57]. It was also shown that this hairpin-like structure and the N-terminal β-sheet-like 
structure were joined by a hinge (residue 17) and one thus obtains two domains (the N-terminal β-
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sheet-like structure and the C-terminal hairpin-like structure) that may move relative to each other 
(Figure 1.4.2.1) [16].  
 
This probably describes the structure of all the pediocin-like bacteriocins that belong to group 1 and 
2 (Figure 1.4.1) as they have a well conserved primary structure in the N-terminal half and they all 
contain either the hairpin-stabilizing disulfide bond between a C-terminal cysteine residue and a 
cysteine residue in the middle of the peptide, or a hairpin-stabilizing tryptophan residue near the C-
terminal end (Figures 1.4.1 and 1.4.2.2). 
 
It is however unclear whether or not the pediocin-like bacteriocins that belong to group 3 (Figure 
1.4.1) also form the three-dimensional structure described for group 1 and 2 peptides, since the 
group 3 peptides all lack the cysteine residues in the C-terminal half (and thus the hairpin-stabilizing 
disulfide bond) and the tryptophan residue near the C-terminal end. The NMR structure of one group 
3 peptide, carnobacteriocin B2, has been reported, and the structure revealed only an amphiphilic α-
helix from residue 18 to 39 [54]. There was no apparent well-defined structuring in the N-terminal 
half nor the C-terminal tail. 
 
1.4.2 Mode of action and orientation in the membranes of pediocin-like bacteriocins 
 
Hybrid bacteriocins constructed by joining  the N-terminal domain of one peptide with the C-
terminal domain of another (using the hinge as the recombination point) display target cell 
specificity similar to the bacteriocin from which the C-terminal end was derived [58]. This indicates 
that the hairpin membrane-permeabilizing C-terminal domain is the major specificity determinant in 
pediocin-like bacteriocins. 
 
Alterations in the C-terminal region by site directed in vitro mutagenesis often alters the target cell 
specificity of the peptide, which further supports the conclusion that the C-terminal domain is the 
specificity domain for the pediocin-like bacteriocins [57, 59]. Apparently, interactions with lipids 
and/or proteins in the interphase and/or hydrophobic phase of the cell membrane determine to a large 
extent the specificity [58]. Recent studies implicate part of the mannose PTS permease as a possible 
receptor molecule for the pediocin-like bacteriocins [60-65].  
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The cationic N-terminal β-sheet-like domain has through site directed in vitro mutagenesis and 
peptide-binding studies been pointed out as the domain that binds the bacteriocin to the target cell 
surface [66, 67]. This initial interaction between the target cell and the β-sheet-like domain is 
electrostatic and presumably non-specific. The hydrophobic/amphiphilic C-terminal hairpin domain 
penetrates then into the hydrophobic part of the target-cell membrane [12, 28, 57, 68], the hinge 
between the two domains providing the  structural flexibility, which enables the C-terminal hairpin 
domain to dip into the membrane. The penetration causes leakage through the membrane, which in 
turn may cause dissipation of the proton motive force (PMF). The cells try to restore this loss of 
PMF by ATP consumption, which again leads to depletion of the cell’s ATP pool [36, 69-71].  In 
Figure 1.4.2.1, the structure and orientation in the target-cell membrane of pediocin-like bacteriocins 
and its interaction with an immunity protein is depicted. 
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Figure 1.4.2.1  A cartoon depiction of the structure and orientation in target-cell membrane of a pediocin-like 
bacteriocin, and interaction with an immunity protein. The bacteriocin is divided into two discrete domains, separated by 
a hinge: the N-terminal β-sheet-like domain that mediates binding to the target-cell surface and the C-terminal hairpin 
domain that determines target-cell specificity and interacts with the immunity protein. 
 
The very similar primary structure of the N-terminal domains (Figure1.4.1) is presumably the reason 
why target cells do not seem to discriminate between different pediocin-like bacteriocins upon initial 
interaction between the peptide and target cells. However, mutational analysis reveals that charged 
residues in the N-terminal half also may influence target-cell specificity to some extent [67]. 
 
All pediocin-like bacteriocins have a central tryptophan residue, usually at position 18 (Figure 
1.4.1). This well-conserved tryptophan residue positions itself in the water-membrane interface (as is 
common for tryptophan residues in membrane penetrating polypeptides [72]), and aids in positioning 
the C-terminal domain correctly in the membrane (Figure1.4.2.2) [27].  
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In addition and as discussed above, most of the pediocin-like bacteriocins (all those that belong to 
groups 1 and 2; Figure 1.4.1) have either a disulfide bridge or tryptophan residue C-terminally. Both 
these features stabilize the hairpin structure [57]. The disulfide bond does so by covalently binding 
the C-terminal end to the central part of the peptide and the tryptophan residue by positioning itself 
in the water-membrane interface in the same manner as the central tryptophan residue (Figure 
1.4.2.2). 
 
Figure 1.4.2.2: A cartoon depiction of the structure and orientation in membranes of pediocin-like bacteriocins. A 
pediocin-like bacteriocin in which the C-terminal hairpin structure is stabilized by (A) a disulfide bridge and (B) 
interface-localized tryptophan residues near the C-terminal end and in the middle of the bacteriocin. Tryptophan residues 
that become localized in the membrane-water interface are indicated by W and the disulfide bridge by –S-S- [27]. 
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1.5 Aim of this study 
 
As discussed above, there is no additional disulfide bridge in group 3 pediocin-like bacteriocins, and 
the last tryptophan residue is positioned more towards the centre of the C-terminal domain (Figure 
1.4.1). The above model describing the structure of pediocin-like bacteriocins that belong to group 1 
and 2 and how these bacteriocins position themselves in membranes (Figures 1.4.2.1 and 1.4.2.2) 
may consecuently not hold for the bacteriocins that belong to group 3. Carnobacteriocin B2 is the 
only group 3 pediocin-like bacteriocin whose three-dimensional structure has been analyzed, and the 
central amphiphilic α-helix was the  only structural unit which was identified [54]. The aim of this 
study was to determine the three-dimensional structure of the group 3 pediocin-like bacteriocin 
curvacin A, and thereby gain more insight into the three-dimensional structure of the pediocin-like 
bacteriocins that belong to this subgroup.  
 
It was of interest to see if these peptides also form a similar two-domain structure as the peptides that 
belong to group 1 and 2. Moreover, insight into the three-dimensional structure of group 3 peptides 
may reveal how these peptides interact with target membranes, information which is vital for 
understanding at a molecular level their mode of action. This information may in turn be important 
for possible future commercial use of these peptides in food industry and medicine.  
 
Three-dimensional structures of polypeptides may be obtained by both X-ray crystallography and 
Nuclear Magnetic Resonance (NMR)-spectroscopy. NMR-spectroscopy was chosen in this study for 
determining the three-dimensional structure of curvacin A. 
 
Curvacin A is a small molecule (4307 Da) that is unstructured in water and requires a membrane to 
be structured. A membrane-mimicking environment is created by using trifluoroethanol (TFE) or 
micelle-forming lipids such as as dodecyl phosphocholin (DPC). In such an environment, NMR 
experiments are easily performed whereas it is not feasible to obtain the crystals needed for X-ray 
crystallography under these conditions.  
 
Two different procedures to produce sufficient amounts of curvacin A for NMR-analysis were 
investigated. One was to clone the curvacin A-enconding gene into an E. coli over-expression 
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system and use this system for production and isolation of curvacin A. The other was to isolate 
curvacin A from the natural curvacin A-producing strain, Lactobacillus curvatus LTH1174. 
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2 Brief Description of Important Methods used in this Study: 
 
2.1 Brief introduction to NMR-theory: concepts and applications 
 
In 1946, Edward Mills Purcell [73] and Felix Bloch [74] independently demonstrated the NMR-
phenomena: absorption of radio-frequency energy due to energy transitions corresponding to 
different states of nuclear spins in a strong, constant applied magnetic field [73]. In NMR, as the 
name indicates, it is the nucleus that is of interest. Nuclei are sensitive towards the electronic 
environment they find themselves in, and as a result nuclei resonate at different (or shifted) 
frequencies depending on the local electronic environment surrounding the atom. Structural 
components and functional groups can be identified based on the observed resonances [75]. 
 
An intrinsic property of many nuclei is the spin angular momentum, which gives rise to magnetic 
moments [76]. Angular momentum is quantized [77].  
 
Electrons, 1H- 13C- and 15N-nuclei share a common spin quantum number s=1/2 and nuclear spin 
quantum number Is= ±1/2. Most biological NMR experiments utilize one or more of the above nuclei 
for investigation. The following discussion considers the nuclei with s=1/2 but is equally applicable 
for considering the case of electrons.  
 
There are two possible states for an s=1/2 nuclei: spin up (denoted ↑ or α) and spin down (denoted ↓ 
or β) associated  I= +1/2 and -1/2, respectively [76]. When no magnetic field is present, states with 
different values of quantum number I are degenerate, i.e. their energy is equal. However, when an 
external applied field is present the different states are no longer degenerate. As a result, the energy 
levels are split in two when a field is present [77]. 
 
The difference in energy is given by 
 
ΔE= Eα-Eβ=hν=γħB0I, 
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where Eα and Eβ denote the energy for the α- and β-states, γ is the gyromagnetic ratio (a measure of 
how strongly magnetic a nuclide is [78]), ħ is the Planck constant h divided by 2π, B0 is the steady 
magnetic field applied and I is the quantum magnetic number. 
 
The application of a magnetic field to a charged particle like the nucleus causes it to precess about 
the direction of the field [77]. The rate at which the vectors precess depends on the nucleus type and 
is proportional to the applied magnetic field [76, 77]. At equilibrium the frequency of precession is 
called the Larmor frequency, νL, and takes the value 
 
νL=-(γ B0)/2π. 
 
At equilibrium the population distribution between the two states follows Boltzmanns distribution 
[77]: 
 
Nα/Nβ= e(-ΔE/kT),  
 
where Nα and Nβ are the populations of the two states, k=Boltzmanns constant and T is the 
temperature. 
 
At equilibrium Nα is slightly more populated than Nβ. This excess of nuclear spins gives rise to a 
bulk magnetisation Mz along the +z-axis (defined axis for equilibrium net magnetisation). In the xy-
plane, however, all the vectors are randomly distributed and their individual contributions cancel out, 
i.e. there is no net magnetisation in this plane [77-79].  
 
Nuclear magnetic resonance occurs when the nucleus changes its spin state driven by the absorption 
of a quantum of energy [78]: By applying radio frequency (RF)-pulses to a system, transitions 
between energy states can be induced. Traditionally, this is pictured as the net magnetisation vector 
along the z-axis flipping down onto the xy-plane [78, 79]. Also, due to phase coherence, net 
magnetisation in the xy-plane can now be observed [77, 79]. Phase coherence is the alignment of all 
magnetisation vectors in the xy-plane: Their contributions no longer cancel out. The evolution of 
magnetisation (which is a product of decay and resonance frequency) is measured [77].  
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There are essentially two relaxation pathways in which the system returns to the original state that is 
measured in an NMR-experiment [75-77]: 1)Relaxation from the xy-plane to the z-axis and 2) 
relaxation within the xy-plane. 
 
In time, the Mz component relaxes back from the xy-plane to the +z-axis [78, 79]. This is referred to 
T1-relaxation or longitudinal relaxation time. It is also referred to as spin-lattice relaxation time, 
because the excess energy is released to the “lattice” (the surrounding system of energy states) when 
spins revert from the β to the α state [76]. 
 
Also, the loss of coherence among spins due to the fact that some spin faster and other slower than 
the actual Larmor frequency, contributes to relaxation. Immediately after a RF-pulse, there is an 
orderly bunch of spins as mentioned above [76]. In time, the spins fan out so that in the end all the 
spins are randomly distributed in the xy-plane. This fanning out is due to random fluctuating 
interactions and field inhomogenities and causes the signal to vanish [75]. The random fluctuating 
interactions give rise to T2 -relaxation or transverse relaxation time. This is also called spin-spin 
relaxation time to reflect that it involves the relative orientations of the spins [76]. 
 
Through the two relaxation pathways, the system relaxes back to equilibrium at a rate dependant on 
the time constants T1 and T2. The signal produced is called an FID (Free Induction Decay), and 
decreases exponentially. A mathematical procedure called a Fourier Transform (FT) shifts the signal 
from a time domain to frequency domain scale [76] (Fig 2.1.1). 
FT
Time Frequency
 
Figure 2.1.1: Schematic description of how the shift from time-domain to frequency-domain by Fourier Transform is 
achieved for a NMR-spectra. 
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By applying different pulses in sequences, one can obtain different information. Techniques and 
pulse sequences have been devised to extract sequential as well as conformational connectivities 
between for example amino acids. The procedures used in this thesis and the information derived 
thereof are described later in the text. 
 
2.1.1 Information from chemical shifts: 
 
All nuclei resonate at a specific resonance, but the exact value of resonance can vary for even the 
same type of nuclei, all depending on the local environment. This phenomenon is called chemical 
shift. 
 
Chemical shifts arise from small changes in electron density around a specific nucleus, and the 
electronic environment therefore influences the difference in shifts seen for different nuclei. That is, 
the electrons induce a small additional electronic field either opposing to or adding to the external 
magnetic field. This leads to shielded and deshielded nuclei, respectively [75]. Hence, a nucleus 
resonates at slightly different frequencies depending on the surrounding electron densities. Chemical 
shifts are reported relative to a reference standard to ensure that the values are independent of the 
applied field and thus a common table of values can be used by all spectroscopists [76]. 
 
Standard chemical shift values for nuclei bonded to different neighbours are tabulated and used to 
identify the signal arising from different functional groups in a spectrum. For example, hydrogen 
atoms of an amino acid resonate at a recognizable frequency depending on which atom it is bonded 
to. There is thus a specific pattern of signals from each amino acid, and this is used to identify each 
residue type in a given protein spectrum. The signals expected for the 20 common amino acids in 
COSY and/or TOCSY 1H-1H 2D correlation spectrums are shown in Figure 2.1.1.1 below. The 
chemical shift values correspond to amino acids in random coil structures. 
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Figure 2.1.1.1 
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Figure 2.1.1.1 continues.  An illustration showing the spin systems of the 20 common amino acid residues in a 
COSY/TOCSY 1H-2D NMR experiment. Only peaks on the left hand side of the diagonal are shown. In a real spectrum, 
identical peaks reflected about the diagonal can be visible. A characteristic pattern of signals results from each amino 
acid from which the amino acid can be identified. All peaks may be shown in a TOCSY spectrum. Filled gray circles 
show diagonal peaks, filled black circles show cross peaks visible in a COSY spectrum, filled black squares show 
additional cross peaks visible in a TOCSY spectrum [80]. Random coil 1H chemical shift values are included [80]. 
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The spin systems have rather complicated names including letters and numbers. The letters refer to 
the different coupled spins. The numbers indicate the number of magnetically equivalent protons. 
For a thorough description, the reader is referred to “NMR of proteins and nucleic acids“, chapter 5 
by Wüthrich [80]. In the work done in this thesis, only the specific patterns of the spin systems and 
the labelling of the atoms are of importance. 
 
Figure 2.1.1.2 exemplifies how the atoms in an amino acid are labelled in NMR-theory.  The first 
carbon in the side chain (attached to the carbonyl carbon) is called the α-carbon. The attached 
proton(s) is(are) the α-proton(s). The subsequent side chain atoms are named by following the Greek 
alphabet. Thus, a proton is labelled α, β, γ, δ or ε according to which carbon in the side chain it is 
attached to. The proton attached to the backbone amide is labelled HN. The protons on the aromatic 
side chains are labelled according to standard numbering. 
 
N
H
H2N
NH O
OH
NH2
Arginine
α
β
γ
δ
 
Figure 2.1.1.2 The amino acid arginine with side chain carbons labelled as is standard in NMR 
 
Chemical shifts are among the easiest data collected from a NMR-spectrum. The values are sensitive 
to the local environment and a deviation from random coil values in chemical shifts is observed 
when a particular residue is known to be part of a secondary structure [81-84]. 15N, Hα- and amid-
protons experience a net upfield shift when in an α-helical conformation and a net downfield shift 
when in a β-sheet conformation. α- and carbonyl-13C-shifts display the opposite, with downfield 
shift for α-helical conformations and upfield shift for β-sheet conformations. For flexible or 
unstructured regions, shifts are close to random coil values.  
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Given the above trends, one can quantitatively measure a certain part of a structure’s flexibility. 
Chemical shift values close to random coil values of a peptide known to be e.g. an α-helix suggest 
that this helix is quite flexible, whereas chemical shifts far from random coil values points at a rather 
rigid structure [83].  
 
Chemical Shift Index (CSI) 
One can predict the secondary structure of a given segment by examining the chemical shifts. 
Especially α-proton chemical shifts show a strong correlation to secondary structural elements. A 
method devised to explore this relationship is the Chemical Shift Index (CSI) [84].  
 
Backbone angles 
There is a relation between chemical shifts of backbone atoms, and secondary structure as mentioned 
above. In addition, these parameters are linked to backbone angles. By comparing chemical shifts 
derived from a new compound with those of an already known structure, φ− and ψ−angles can be 
predicted [82, 83, 85]. These angles can then be used as an additional parameter alongside NOEs and 
J-couplings when calculating the structure. Figure 2.1.1.3 illustrates between which atoms the φ− 
and ψ−angles are found. 
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Figure 2.1.1.3 The torsion angles φ and ψ between 
backbone atoms in amino acids. The angle of rotation 
around the N-Cα bond is the φ-angel, and rotation 
around the Cα –C’ bond is the ψ-angel. A Plane of a 
backbone peptide with the side chains oriented above of 
the plane (filled wedge) or below the plane (striped 
wedge). The arrows indicate the rotational bonds. B 
Projection of the peptide in part A, viewed along the 
bond of rotation from the atom drawn as a small circle 
to the atom drawn as a big circle. The thick black line 
represents the bond between the atom drawn as a small 
circle and its neighbouring atom. The thin black line 
represents the bond between the atom drawn as a big 
circle and its neighbouring atom. The atoms are 
coloured as in A.
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2.1.2  Scalar (spin-spin) couplings 
 
Electrons form chemical bonds between nuclei, and this interaction is known as scalar or spin-spin 
coupling. The interaction is measured by the scalar coupling constant nJab, where n denotes the 
number of covalent bonds separating the two nuclei a and b [86]. 
 
With scalar coupling (J-coupling), magnetisation is transferred through bonds: All the spins 
influence each other in a predictable way, and this can aid in determination and labelling of 
functional groups [75]. In a J-coupled correlation spectrum, all protons within an amino acid have 
the possibility to couple with each other. (Correlation with protons on adjacent amino acids is so 
small that it is not visible.) The basis for this is described under the TOCSY section (2.1.5.1.2). 
The most important couplings from a spectroscopist’s point of view is for n=1-4 [86]. Couplings 
between nuclei cause splitting of the NMR-signal. Weakly and strongly coupled two-spin systems 
are referred to as AX- and AB-spin systems, respectively [86]. 
 
J-values for n=1-3 are dependant not only on internuclear distance but also molecular structure. As 
such, one can obtain possible parameters for structure calculations from scalar couplings [79]. 
Particularly 3J-couplings (vicinal couplings) are useful in this respect. The value is dependant on 
substituents, the distance between the two carbon atoms involved, H-C-C-H bond angle, along with 
torsional and/or dihedral angles, with the latter angle being of greatest interest [79]. 
 
3J-couplings vary in magnitude in a bond-angle dependent manner. The relationship between the 
coupling constant J and the dihedral angel φ (Figure 2.1.1.3) are given by the Karplus equation [76]. 
Consequently, J-couplings can be used to measure dihedral angles and thus conformational 
arrangements around bonds.  
 
2.1.3 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) as internal standard; Chemical shift 
referencing 
 
When listing chemical shifts for the various spin-systems, it is important that there is a common 
reference. Wishart and colleagues  [87] have investigated the properties of different commonly used 
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reference compounds. The conclusion reached was that DSS is the best standard for both 1H and 13C 
chemical shift references. Also, updated tables of random coil values calculated experimentally with 
DSS as an internal standard are provided [88]. These tabulated values are in good agreement with 
statistically calculated chemical shifts [89], which further supports the reported work. This study 
employs DSS as an internal standard. 
 
2.1.4 Linewidth and signal:noise-ratio 
 
As the molecular mass increases, so does the rotational correlation time. This has a profound effect 
on the linewidth of the peaks; the longer the correlation time, the broader the lines [86]. 
Consequently, the peaks become less well defined and they overlap. The decreased sensitivity can be 
understood by considering the small 3J scalar couplings that coherence transfer relies on: as the 
linewidths broaden, they become comparable or even greater than the actual J-values we try to 
measure [86]. Linewidth thus affects the resolution of a spectrum, but it also affects the signal-to-
noise ratio [86]. 
 
Signal-to-noise ratio, or sensitivity,  is proportional to the number of scans in an experiment [90]. 
More specifically, it improves with the square root of the number of scans in an experiment [77]. 
 
2.1.5 Two-dimensional NMR-techniques: COSY, TOCSY, NOESY and HSQC. 
 
2D NMR was introduced for the first time by Jean Jeener during a lecture at Ampére Summer 
School in former Yugoslavia in 1971 [91], and the principles he outlined still govern today’s 
techniques. Four stages of a 2D-experiment can be outlined; preparation, evolution, mixing and 
acquisition (Figure 2.1.5.1) [86, 90, 92]: 
Preparation Evolution Mix Aquisitoion
t1
t2  
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Fig 2.1.5.1: Anatomy of a 2D experiment. Each box represents a stage in the recording process of a 2D NMR spectrum. 
The two time domains t1 and t2 are acquired during the evolution period and the acquisition period, respectively. 
 
The first stage, the preparation phase, can consist of a single pulse or a more complex sequence of 
pulses that perturbate the system from its equilibrium state to a desired preparatory state. During the 
evolution period (stage 2), successive increments of t1 give the F1 dimension in the finished 
spectrum. In stage three, the mixing, coherence is transferred from one spin to another. This part of 
the experiment defines what kind of correlation is observed between the two dimensions, i.e. what 
kind of information the spectrum provides. Thus, here lies the key to obtaining useful information 
from a 2D spectrum. In the fourth and last stage, the acquisition step, the FID is recorded and this in 
turn gives the F2 dimension. 
 
The two frequency domains are, as mentioned, derived from t1 and t2, where t1 is incremented 
during successive runs. The effect is that the evolutions of spins are recorded at different stages and 
a picture of the chain of events is gained. In other words, we can follow the magnetisation as it 
travels from one nucleus to another and from this establish which nuclei are connected and in what 
way they are connected (through bonds, space or both). 
 
The duration of the mixing time determines which peaks that are visible in a given spectrum. With 
short mixing times, the magnetisation has no time to travel down a side chain. As a result, the α-
protons will generally be more intense than the β-protons along the amide shift, which again will be 
more intense than a γ-proton. Longer mixing time is essential to be able to see the protons at high 
shifts, most notably the δ- and γ-protons of valine-, isoleucine- and leucine residues.  
 
2.1.6 COSY (COrrelation SpectroscopY) 
 
COSY is one of the first 2D techniques to be described [92]. Cross peaks arise from protons 
separated by two or three bonds, where the coupled spins cause coherence transfer [86]. For proteins, 
particularly pairs of protons separated by three bonds (3J scalar coupling), such as methyl groups in 
the fingerprint region and glycin-residues, are important peak contributors in COSY spectra [86]. A 
limitation of this technique is that correlations between spins more than three bonds apart cannot 
easily be assigned. 
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2.1.7 TOCSY (TOtal Correlation SpectroscopY) 
 
Also called HOHAHA (HOmonuclear HArtmann-HAhn), a TOCSY experiment exploits that 
magnetism can be transferred through several couplings during the mixing time [93]. Pulses are 
applied such that the Hartmann-Hahn condition is satisfied [77]. Under these conditions 
magnetisation is transferred very efficiently between coupled nuclei, e.g. an amino acid. Only 
intraresidual couplings are observable in TOCSY [86]. In a TOCSY experiment one obtains 
information about which spins are coupled together as a spin system, and hence what type of amino 
acid that gives rise to a particular signal. By utilizing a long enough mixing time, magnetism is 
transferred completely through a spin system, and a complete set of cross-peaks for spin-coupled 
systems can be recorded [77].  
 
Unfortunately, at long mixing times some signals from amino acids with shorter chains can have lost 
intensity. One should therefore use several different mixing times when recording spectra and 
compare the results [86]. 
 
TOCSY is a widely used method for locating each amino acid residue in a protein with respect to the 
type of residue, but not to a specific residue. For example, cysteine, histidine, phenylalanine, 
tryptophan and tyrosine residues all give rise to the same array of connected cross peaks (Figure 
2.1.1.1). We can from a TOCSY spectrum only identify a spin system as belonging to this group, but 
not which amino acid in particular. Alanine, however, has a unique signal and a specific assignment 
can be made from TOCSY. Even so, if there is more than one alanine residue in the sequence one 
can only state that a signal comes from an alanine but not which one [94]. 
 
Identification of spin-systems; TOCSY 
The first step in the assignment procedure is to decide which peaks belong to the same spin-system; 
that is to the same amino acid. A TOCSY-spectrum provides this kind of information. As mentioned 
in the description of TOCSY-spectra above, only the type of spin-system can be determined in this 
step. Figure 2.1.7.1 illustrates how the peaks in a spin-system are connected in different regions of a 
TOCSY-spectrum. 
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Figure 2.1.7.1: An illustration of how spin systems may be identified in a TOCSY spectrum. HN refers to the proton 
connected to the backbone amide nitrogen, α to the proton connected to the Cα in the side chain and β to the Cβ. 
Similarly, protons connected to carbons in longer side chains are labelled according to the carbon it is associated with. 
Thus, the peaks are labelled according to the protons that contribute to a particular peak in the same order as the 
magnetisation travels.  
 
By tracing all the peaks aligned through a line vertically from an amide-shift on the left-hand side of 
the diagonal (the amide region), the potentially scalar coupled peaks are identified. To verify that the 
peaks are coupled and not the result of another spin system, the corresponding peaks originating 
from the α-proton and β-protons in the alkyl region are also traced. An array of peaks like the one in 
Figure 2.1.7.1 shows all possible connections in a TOCSY spectrum for an AMX spin-system.  
 
Names of the different atoms are given in Figure 2.1.7.1, exemplified by the peaks in the fingerprint 
region. In short, a peak is named by stating the origin of the magnetisation first and the destination of 
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the magnetisation last. Thus, the peak identified as α/HN is a result of magnetisation travelling from 
the α-proton to the amide proton, whereas the HN/α peak results from magnetisation travelling in 
the opposite direction; from the amide-proton to the α-proton. 
2.1.8 NOESY (Nuclear Overhauser Effect SpectroscopY); the Nuclear Overhauser 
Effect 
 
Sequential assignment is completed by correlating protons that are close in space [86]. NOESY 
relies on the nuclear Overhauser effect (NOE) that links nuclei that interact through space, and are 
less than 5Å apart [77].  
 
Nuclear Overhauser Effect 
The intensity of an NMR-signal is proportional to the difference in population of two energy levels 
where nuclear resonance transition occurs [79]. Dipolar coupled nuclei do not relax independently 
[86]: Cross-relaxation (relaxation between two spins) leads to magnetisation transfer between the 
spins and the resulting change in intensity is known as the nuclear Overhauser effect [90]. The rate 
of cross-relaxation, and thus the NOE enhancement factor, is among others dependant on the 
distance between the coupled nuclei and the motion of the molecule [90, 95]. Cross relaxation leads 
to changes in the population of the two coupled spins. This change of population can again lead to 
peaks with stronger/smaller intensities as a result of the NOE-effect. Equalizing the population 
difference (saturation) of a spin S strongly affects the longitudinal magnetisation of a coupled spin I 
caused by the increased population difference of this spin [86, 90, 95]. The system is now not in a 
state of equilibrium and returns to equilibrium through relaxation mechanisms, mainly through 
dipole-dipole interactions [95]. NOE and dipole-dipole relaxation mechanisms are thus closely 
connected [79]. During cross relaxation, magnetism is transferred through dipolar couplings between 
the interacting nuclei, and the intensity of NOE-peaks is inversely proportional to the internuclear 
distance to the sixth power [77]. The intensity of the peaks is evaluated by integration, and classified 
as being strong, intermediate or weak [77].  
 
In a 2D NOE experiment, such as NOESY, positive magnetisation is exchanged between nuclei [90]. 
By eliminating what peaks are due to scalar coupling (from comparison with the scalar coupled 
techniques described above), sequential assignment and distance constraints are derived from the 
remaining dipolar NOE-peaks [90].  Mainly three connectivities are utilized in this respect: HN-HN, 
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HN-Hα protons and HN-Hβ protons [90]. As a rule of thumb, the strongest NOE cross-peaks come 
from protons on sequentially neighbouring residues [80, 94]. 
 
For molecules with long correlation time τc, strong positive cross-peaks arise due to NOE-
enhancement [90, 95]. Although curvacin A is a small polypeptide, it is associated with micelles (or 
membranes in biological environments). Curvacin A moves together with the micelles and hence 
behaves as if it was much larger. This results in slow rotational motion of the molecule and long 
correlation time [80, 90]. We therefore expect positive cross-peaks in the NOESY-spectrum of 
curvacin A.  
 
Sequential assignment of the spin systems; NOESY 
After having identified the spin systems, the next step is to sequentially assign the spin systems by 
identifying the intraresidual NOE couplings. This information is provided by a NOESY spectrum. 
Figure 2.1.8.1 schematically illustrates how sequential NOEs are located in a NOESY spectrum. 
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Figure 2.1.8.1: Illustration of how interresidue NOE connections in a NOESY spectrum can be identified. Blue and black 
peaks are intraresidue peaks already identified in the TOCSY spectrum. The red and green peaks are interresidue α-to-
amide and amide-to-amide peaks, respectively. The horizontal arrows indicates how the cross peaks are read out. This is 
especially important in the fingerprint region, where the position of an interresidual NOE peak is sequence specific. See 
the text below for details. 
 
In the fingerprint region, sequential couplings between side chain protons are identified. Starting at 
the α-proton of residue i and moving horizontally along the ω2-axis one should find a strong peak 
along the amide shift of residue i+1. This is the interresidual NOE peak between the α-proton of 
residue i and the amide proton of residue i+1. Following in the same manner, starting at the α-proton 
of residue i+1 and moving horizontally along the ω2-axis one should find a strong interresidual NOE 
peak along the amide shift of residue i+2. 
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In the same manner, cross peaks from β-protons to amide protons and other side chain protons 
supports the connection of the spin systems established by tracing cross peaks between α-protons 
and amide protons (not shown in Figure 2.1.8.1): Starting at the β/γ-proton of residue i and moving 
horizontally along the ω2-axis one should find a peak along the amide shift of residue i+1. This is the 
interresidual NOE peak between the β/γ-proton of residue i and the amide proton of residue i+1. 
Interresidual cross peaks between the amide proton of a residue and side chain protons other than the 
α-proton of a neighbouring residue are usually weaker than the cross peak between α-proton and 
amide proton on neighbouring residues. 
 
One could also alternatively search for sequential connections in the opposite direction: Moving 
vertically up or down from the α-proton of residue i, one should find a strong interresidual NOE 
peak. By looking horizontally along the ω2-shift of this interresidual peak one should find the α-
proton of residue i-1. This can be visualized by following the arrows from residue i+1 to i in Figure 
2.1.8.1 in the opposite direction as to what is drawn.  
 
Usually, a string of three consecutive spin systems is enough to determine the sequential location of 
these spin systems. However, sometimes more than three consecutive spin systems have to be 
identified to pick out a unique sequence. The aim is to locate a string of consecutive spin systems 
that can only be positioned one place in the sequence, and if there is more than one possible position 
for the string of spin systems identified (irrespectively of the number of consecutive spin systems), 
neighboring spin systems must be located. The number of residues in the molecule, type of spin 
systems represented in the sequence and their distribution along the sequence determines how many 
consecutive spin systems are needed to assign that particular sequence with confidence.  
 
In the amide region, connections can be identified as described in Figure 2.1.8.1. Amide proton to 
amide proton on both sides of the diagonal may be identifiable. One cannot determine the direction 
of the connections from the backbone connections, only that the spin systems are connected 
sequentially. These connections are used methodically to verify the sequential connection found by 
tracing the cross peaks in the fingerprint region as described above. They are also important as 
distance constraints used for structure calculation in subsequent steps. 
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Aromates: 
There are four aromatic residues in curvacin A; two tryptophans (W16 and W34) and two tyrosines 
(Y4 and Y9). The protons on the aromatic rings have characteristic topology, and correlate with the 
aliphatic side chain protons in NOESY spectra. By connecting the ring spin systems and the aliphatic 
AMX-spin systems identified in a TOCSY spectrum by the use of a NOESY spectrum, the aromatic 
residues can be singled out from the rest of the AMX-spin system residues. 
 
2.1.9 Heteronuclear experiments:  
 
In heteronuclear experiments, either 13C or 15N are used in combination with 1H in 2D heteronuclear 
experiments in addition to the above homonuclear experiments. One thus obtains 1H/13C and 1H/15N 
2D spectra. 
 
In heteronuclear experiments of coherence transfer, rf pulses are applied at more than one frequency 
to manipulate two or more nuclei [86]. Utilizing more than one nucleus greatly improves the 
resolution in as much as overlapping proton resonances can be separated with respect to the different 
13C or 15N chemical shifts associated with them, and finally aids the assignment procedure by simply 
contributing correlation between different species [90]. 
 
 By adding another incremented dimension and another mixing period, the heteronuclear experiment 
can be expanded from 2D- to a 3D-experiment. (For example a 1H/1H/13C 3D spectrum) 
 
2.1.10 13C and 15N HSQC (Hetronuclear Single Quantum Correlation) 
 
HSQC makes use of a pulse sequence called INEPT (Insensitive Nuclei Enhanced by Polarization 
Transfer) to transfer magnetisation from the sensitive proton nucleus to the insensitive 13C- or 15N- 
nucleus via direct 1J-couplings during the mixing period. The direct, or observed, F1 dimension is 
thus obtained from the insensitive nucleus whereas the indirect F2 dimension still stems from the 
proton. This creates a 2D heteronuclear spectrum. It is possible to run experiments where the direct 
dimension is read out on the insensitive nucleus (13C-or 15N), but indirect (or proton) detection, 
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where the magnetisation is transferred back to the sensitive proton before it is read out, is used 
whenever possible in order to maximize sensitivity [86]. 
 
HSQC transfers correlation through H-C and H-N bonds. This is thus a 1J-coupled correlation 
technique, and can be used in sequential assignment of a molecule. For carbon, one can expect 
correlation peaks throughout the entire carbon-bonded side chain of an amino acid. For nitrogen, 
mainly the amide backbone cross peaks are of interest, but for some of those amino acids with 
amides in their side chains, additional peaks are expected.  
 
It is possible to perform structural determination from homonuclear experiments [96], as long as the 
proteins are of modest size (molecular weight less than 10 000). Even so, it is useful to run J-
correlated experiments such as HSQC on natural abundance of 13C and/or 15N to exploit the 
additional chemical shift-data from such experiments [97]. 
 
2.1.11 Structure calculation, the CYANA-program: 
 
When having identified  (preferably) all spin systems and labelled them according to the amino acid 
sequence using scalar coupling, additional information yielding distance constraints such as NOE-
cross peaks, volumes of these peaks, three-bond J-couplings and chemical shifts is used to calculate 
a plausible 3D-structure [86]. The success of such a strategy for structure calculation depends on an 
as complete list of chemical shift assignments for protons as possible [98]. It is doable for an 
experienced spectroscopist to calculate structures manually for small molecules, but it is 
cumbersome and time-consuming. Rather, one of several computerized model-simulating 
programmes is used. Here, CYANA (Combined assignment and dYnamics Algorithm for NMR 
Applications) is used for automated NMR structure calculation [99, 100].  
 
Basically, what CYANA does is through several refining cycles of conformational computations to 
reach a structural model with the least deviation from the experimental data  [101]. The calculated 
structure with minimum energy is the structure that has maximum compatibility with the 
experimental data. This iterative process utilizes preliminary structures from earlier cycles to reduce 
ambiguities of cross-peak assignments. Additional selection criteria for cross-peaks and NOE-
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assignments are added after each cycle, yielding better structures in the process. Cycle one is thus 
the most crucial one, being the only for which a previous structure is not available [99, 101].  
 
The key conformational data-input are upper distance limits derived from nuclear Overhauser effects 
(NOEs) [100].  
 
A difficulty with NMR is the unreliability with which all information can be accurately assigned and 
labelled. As mentioned above, distances constraints from NOEs are important for structure 
calculation. However, a majority of these NOE cross-peaks cannot be unambiguously assigned, i.e. 
there is more than one possible assignment for most of the peaks. CYANA overcomes this obstacle 
in several ways. First, all ambiguous cross-peaks are treated as the superposition of the signals from 
each of its multiple possible assignments, and weighing them inversely proportionally to the 
corresponding interatomic distance. As long as all the correct assignments are among the 
assignments that are selected, the distance constraint is never falsified, even though incorrect 
assignments are also included [100].  
 
Constraint combination takes the above a step further; assignment from different, often unrelated, 
cross-peaks are combined to generate distance restraints.  
 
Furthermore, the concept of network anchoring is a powerful tool for eliminating false conclusions. 
The basis of network anchoring are that each NOE assignment must be connected to all other 
assignments in a network without contradictions. This ensures that “lonely” constraints from e.g. 
unstructured coil-regions are not falsely forced into a defined structure [100]. 
 
The actual calculation performed by CYANA, is carried out by defining a target function that 
measures the agreement between a structure and a given set of constraints [99, 101]. A low target 
function value reflects a conformation that satisfies the constraints more closely than another with 
higher function value. Thus, best agreement between constraints and a calculated 3D structure is 
defined as the set giving the lowest target function value.  
 
Simulations done with different chemical shift assignments left out show that at least 90% of the 
shifts must be assigned for a satisfactory result. If some “essential” assignments that contribute 
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strongly to the structure are left out, a higher percentage might be necessary for correct structure 
calculation [98, 100].  
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2.2 Other methods used in this thesis: 
 
2.2.1 Circular Dichroism, CD: 
 
Biopolymers such as proteins rotate the plane of plane polarized light, and a CD experiment 
measures the difference in absorption of left and right circularly polarized light [102]. The 
difference, or ellipticity, ΔA between left and right circularly polarized light is plotted as a function 
of wavelength in a CD spectra. Secondary structure elements such as random coil, α-helix and β-
sheet affect the spectra and give characteristic curves [102]. The difference in the curves are mainly 
due to asymmetry in the polypeptide backbone as a result of different conformations [102]. A CD-
spectrum can be used to quantitatively estimate the relative percentage of the different secondary 
structure elements in a sample, but cannot be used to determine where in the sequence these 
elements are [102].  
 
Even if not giving the whereabouts of structural elements, such a spectrum can give valuable 
information as to whether a polypeptide is structured at a given set of conditions and at what 
concentrations of these conditions optimal structuring is observed.  
 
 
2.2.2 Matrix-Assisted Laser Desorption Ionisation Time of Flight Mass 
Spectrometry (MALDI-TOF MS): 
 
Two major applications of mass spectroscopy make it an attractive technique for analysis of 
bioorganic molecules: the ability to elucidate primary structure, and mass determination of high 
accuracy [103]. In addition, the method displays very high sensitivity.  In the work presented here, 
the latter application has been used to verify the purity and mass of curvacin A in fractions from 
reverse-phase chromatography, and only this aspect of MS will be considered here. 
The Laser Desorption Ionisation -technique (LDI) is well suited for analysis of large proteins and 
peptides varying from several hundred to several thousand Daltons [103], and differentiates species 
based on their different mass:charge (m/z) ratio in an MS spectrum [104]. When in an applied 
magnetic field, charged species with mass m and velocity v will be deflected by a degree dependant 
on mass [102]. When the signal is plotted as a function of time, peaks corresponding to ions of 
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different mass will appear at different times [104]. Thus, accurate mass determination can be 
achieved by the known relationship between  TOF and m/z-ratios [103, 105].  
 
Briefly described, in MALDI TOF a sample is ionised by UV-irradiation to charged particles and 
accelerated by an electric or magnetic field. The ions are all accelerated to the same velocity and 
hence only the mass has an impact on deflection. The time an ion require to arrive at the detector is 
measured (time of flight), and m/z is calculated from this [104, 105]. Masses can be determined with 
accuracies up to ±0,01% (i.e. ±0,5 Da for curvacin A) [102, 104]. 
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3 Materials and Methods: 
3.1 Production of curvacin A 
 
Two procedures for producing curvacin A in amounts sufficient for NMR-analysis were 
investigated: 1) Cloning of the curvacin A-encoding gene into an Eschericia coli (E. coli) over-
expression system (described in section 3.1.1 below) and 2) Production of curvacin A from its 
natural producer, Lactobacillus curvatus LTH1174 (see section 3.1.2 below). 
 
3.1.1 Cloning and over-expression of curvacin A in E. coli-cells 
 
Briefly, the curvacin A gene isolated from LAB LTH1174 was ligated into a pET 3a plasmid 
(Novagene) and transformed into E. coli for over-expression (Figure 3.1.1.1). The plasmid (pET 3a-
vector + curvacin A gene) was first transformed into E. coli DH5α–cells for cloning of the curvacin- 
encoding plasmid. Subsequently, the plasmid was transformed into E. coli BL21(DE3)pLysS–cells 
(Stratagene) for protein expression. 
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Methionine
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Figure 3.1.1.1: Description of constructed plasmid for over-expression of curvacin A in E. coli. A Schematic drawing 
illustrating the construction of pET3a plasmid with incorporated curvacin A gene. The curvacin A gene was incorporated 
by cutting the pET3a plasmid with restriction enzymes Nde I and Bam HI and subsequently ligating in the curvacin A 
gene with complementary ligation sites. B Detailed drawing of the inserted curvacin A gene (red) and the primers 
attached. The primers are the components flanking the curvacin A gene on either side. Blue: Cutting sites for the 
restriction enzymes BamHI and NdeI. Yellow: A histidine tag (histag). Green: C-terminal methionine residue of curvacin 
A-forward primer. 
 
Table 3.1.1.1 shows the primers used in the PCR-reaction. 
 
Table 3.1.1.1: The two oligonucleotides used in the PCR-reaction for amplification of plasmids isolated from 
Lactobacillus curvatus LTH 1174 (Curvacin A forward and Curvacin A reverse), and the two oligonucleotides used in 
the mutagenesis of methionine 30 to alanine (Curvacin A M30R and Curvacin A M30F).  
Name Oligonucleotide sequence Notes 
Curvacin 
A forward 
5’-CGT-CTC-TAC-ATA-TGT-CGC-ATC-ATC-ATC-ATC-
ATC-ACA-TGG-CAT-GAT-CTT-ATG-GCA-ACG-GTG-TTT-
AC-3’  
 
Histag underlined, methionine codon in 
bold and underlined, and beginning of 
curvacin A gene in italic 
Curvacin 
A reverse 
5’-CTA-GAC-GGA-TCC-TTA-TTA-TGC-TCC-AGC-TAA-
ACC-ACT-A-3’ 
 
BamHI site underlined and M41A 
mutation codon in bold and underlined. 
Curvacin 
A M30R 
5’-CCA-GCC-GCT-AAT-TGC-ACC-ACC-AAT-AAT-ACT-
TTG-3’ 
                                                                                    
M30A mutation codon in bold and 
underlined. 
Curvacin 
A M30F 
5’-CCA-AGT-ATT-ATT-GGT-GGT-GCA-ATT-AGC-GGC-
TGG-3’                                                                                    
M30A mutation codon in bold and 
underlined. 
MATERIALS AND METHODS 
 38
Cleavage of the fusion peptide and liberation of mature curvacin A were done by cyanogen bromide 
(CNBr) essentially as described before [106]. CNBr specifically cleaves at the C-terminal side of 
methionine residues. Since curvacin A contains two methionine residues, it was necessary to remove 
these by site directed mutagenesis in order to get full-length curvacin A-peptide after CNBr-
cleavage. Thus, the curvacin A reverse- oligonucleotid was designed to change the C-terminal 
methionine (residue 41) of curvacin A to alanine, and another set of oligonucleotides were 
constructed to susbstitute methionin 30 to alanine. The methionine residue needed for CNBr-
cleavage was encoded by the curvacin A forward-oligonucleotide which also encodes for the N-
terminal histag (Figure 3.1.1.1B). This methionine will, before purification of curvacin A on the 
Äkta FPLC system, provide the cutting seat for cyanogen bromide (CNBr) cleavage of the histag to 
release the mature protein.  
 
Cloning of curvacin A into an E. coli BL21(DE3)pLysS-vector for over-expression: 
Lactobacillus curvatus LTH 1174 [48] was  grown overnight in 10 ml of MRS. After sentrifugation, 
the cell pellet was resuspended in QiAgene cell resuspension solution and lysozym treated before 
cell lysis and completion of the QiAgene procedure for isolation of plasmids mini prep, as described 
in the producer’s User Manual (QiAgene). The isolated plasmids were analysed on a 1% agarose gel 
and the curvacin A gene was then amplified by using the oligonucleotid set shown in Table 3.1.1.1 
and a standard PCR-reaction on a MJ Research PTC-200 Peltier Thermal Cycler.  
 
The PCR-product and the pET3a plasmid were cut with restriction enzymes NdeI and BamHI 
(Fermentas), and purified on a 1% agarose gel and by using the GFXTM -kit as described in the 
GFXTM PCR DNA and Gel Band Purification Kit Manual from Amersham Biosciences. 
 
pET 3a was furthermore treated with the enzyme Calf Intestine Alkaline Phosphatase (CIAP), also 
from Fermentas, to minimize the amount of vector that re-ligated with itself. CIAP specifically 
cleaves off the phosphate group at both 5’ and 3’ end of DNA/RNA- backbones. Hence, ligation of a 
5’or 3’ end of pET3a together with the complementary strand from curvacin A with intact 
phosphategroup is more likely than re-ligation of the vector itself. 
 
The purified curvacin A PCR-products were then ligated into the pET 3a-vector (Novagene) (Figure 
3.1.1A), using the procedure described in the Fermentas Manual.  
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The resulting ligmix was thereafter transformed into chemo-competent E. coli DH5α-cells and 
grown over night on LB agar plates containing 100 μg ampicilin/ml (Biolabs Manual). Colonies 
were picked from agar plates the following day, and left to grow overnight in LB-medium, 
supplemented with ampicillin. Plasmids with incorporated curvacin A gene were identified on a 1% 
agarose gel and by using PCR and the oligonucleotides shown in Table 3.1.1.1. 
 
In order to remove the last methionine residue in curvacin A, the ATG codon encoding it was 
substituted to GCA encoding alanine by using the Quick Change Site-Directed Mutagenesis kit 
(Stratagen) and the oglionucleotides shown in Table 3.1.1.1. 
 
The mutated plasmids were then transformed into E. coli DH5α-cells with selection on agar plates 
containing 100 μg ampicillin/ml. After harvesting the colonies, the plasmids were isolated (QiA 
gene Miniprep Manual) and the DNA was sequenced using MegaBase DNA analysis system. 
Plasmid with the desired insert was transformed into E. coli BL21(DE3)pLysS-cells and grown on 
agar plates containing 100 μg ampicillin/ml and 30 μg chloramphenicol/ml for selection. 
 
Induction and over-expression of curvacin A in E. coli BL21(DE3)pLysS: 
Cultures grown over night in 3 ml of LB-medium containing chloramphenicol (30 μg/ml) and 
ampicillin (100 μg/ml) were centrifuged. The cells were washed twice with fresh LB-medium to 
remove the enzyme penicillinase that inactivates ampicillin. The cells were transferred to 100 ml of 
LB-medium containing ampicillin and chloramphenicol. The cultures were left to grow to optimal 
density (OD 0.5) before isopropyl-beta-D-thiogalactopyranoside (IPTG) (Fermentas) was added. 
The E. coli BL21(DE3)pLysS expression system contains fragments of the bacteriofag T7 DNA that 
among other contain the T7 RNA polymerase. IPTG indirectly induces the T7 RNA polymerase, 
which then transcribes the target gene (curvacin A). After inoculation for about two hours, the cells 
were lysated by three alternative chemicals; BugbusterTM/Benzonase, 6 M Guanidine 
HydroChloride (Gu-HCl) (Buffer A, Table 3.1.2) and 8 M urea (Buffer B, Table 3.1.2). The culture 
was centrifuged and the cleared lysate purified on a Histag binding column, Ni-NTA His-Bind® 
Resin (Novagene) as described in the producer’s manual.  
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Table 3.1.2: Buffers used upon purification of curvacin A from E. coli BL21(DE3)pLysS-cells 
Buffers Content 
A 6 M Gu-HCl; 0.1 M NaH2PO4; 0.01 M TrisCl; pH=8 
B 8 M urea; 0.1 M NaH2PO4; 0.01 M TrisCl; pH=8 
C As B, but pH=6.3 
D As B, but pH=5.9 
E As B, but pH=4.5 
  
 
The lysates were mixed with a 50% Ni-NTA His-Bind slurry (Novagene) before application on the 
column. 
 
The column was washed with 2x4 ml buffer C (Table 3.1.2) before the recombinant protein was 
eluted with 4x0.5 ml of buffer D and 4x0.5 ml of buffer E (Table 3.1.2), respectively. The combined 
fractions of protein eluated with buffers D and E was then ready for CNBr-cleavage and purification 
on the Äkta FPLC-system. 
 
3.1.2 Production of curvacin A by its natural producer 
 
For production of curvacin A by its natural producer, Lactobacillus curvatus LTH1174, the producer 
was seeded from a -80oC stock to 10 ml MRS broth (Oxoid) and cultured over night at 30 oC. This 
10 ml culture was then transferred to 2 L of MRS broth which was cultured over night, and a 
stationary phase culture was obtained, from which curvacin A was isolated as described in section 
3.3 below. 
 
3.2 Bacterial Strains and Bacteriocin Assay 
 
By using a mircotiter plate assay system, bacteriocin activity was measured as described previously 
[59, 107, 108]. Each well of the microtiter plate contained bacteriocin fractions at twofold dilutions 
and the indicator strain Lactobacillus sake NCDO 2714 in 200 μl of MRS broth. The microtiter plate 
cultures were incubated over night at 30oC and by thereafter measuring spectrophotometrically at 
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600 nm with a Tecan Sunrise microplate reader, the growth inhibition of the indicator organism was 
determined. 
 
3.3 Isolation of curvacin A by ion exchange and reverse phase chromatography 
 
Isolation of curvacin a was carried out by using a newly established purification protocol [109]. 
 
Overnight cultures of curvacin A were applied directly on a 3 ml Sepharose Fast Flow cationic 
exchange column. The column had been equilibrated with 100 ml of 20 mM sodium phosphate, pH 
5.2. About 0.5 l of over-night culture was applied per run. After application, the column was first 
washed with 100 ml of 20 mM sodium phosphate, pH 5.2, and then washed with 30 ml of 0.15M 
NaCl in 20 mM sodium phosphate, pH 5.2. The sample was eluted with 40 ml 1 M NaCl in 20 mM 
sodium phosphate, pH 5.2. 
 
The eluent obtained from the cationic exchange column was applied to a 3 ml RESOURCE RPC 
reverse phase column on the Äkta purifier-system. Curvacin A was then eluted from the column with 
a linear elution gradient from 0% (v/v) 2-propanol, 0.1% (v/v) TFA to 50% (v/v) 2-propanol, 0.1% 
(v/v) TFA. The elution volume was 60 ml, and the flow speed 1.5 ml/min. The absorbance at 280 nm 
as a function of ml eluent was recorded.  
 
3.4 Analysis of curvacin A on a reverse phase column using the SMART-System (Micro-
Preparative/Analytic Chromatographic System) 
 
To verify the degree of purity of isolated curvacin A, the SMART system with an analytical (μRPC 
C2/C18 SC.2.1/110) reverse phase column was used. A linear gradient from 0% (v/v) 2-propanol, 
0.1% (v/v) TFA to 30% (v/v) 2-propanol, 0.1% (v/v) was applied. The eluent volume was 2 ml, and 
the flow speed 100 μl/min. The absorbance at 214, 254 and 280 nm as a function of ml eluent was 
recorded. 
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3.5 Analysis of purified curvacin A by MALDI-TOF MS 
 
To verify the identity and purity of the isolated curvacin A, MALDI-TOF MS with a reflector mode 
was used. The matrix consisted of a 1:1 ratio of 3% TFA and acetonitril, saturated with a-cyano-4-
hydroxycinnamic acid. 
 
3.6 CD Measurements of curvacin A 
 
CD spectra were recorded by using a Jasco J-810 spectropolarimeter (Jasco International Co., Ltd., 
Tokyo Japan) calibrated with ammonium D-camphor-10-sulfonate (Icatayama Chemicals, Tokyo 
Japan). All the measurements were performed by titrating curvacin A at a concentration of 0.15 
mg/ml with increasing concentrations of DPC (final DPC concentration of 16 mM; CDN isotopes, 
Quebec Canada). Measurements were performed at various temperatures, from 20-55 oC, using a 
quartz cuvette (Starna, Essex England) with a path length of 0.1 cm. Samples were scanned 5 times 
at 50 nm/min with a band width of 1 nm and a response time of 1 s, over the wavelength range 190 
to 260 nm. The α-helical content of the various peptides under different solvent conditions was 
determined by a single point method using the mean residual ellipticity at 222 nm ([θ]222) [110, 111] 
and the equation below: 
 
fH =[θ]222 /(-40,000(1-2-5/n)) 
 
where fH is the α-helical content and n is the number of peptide bonds. 
 
3.7 NMR Sample Preparation for curvacin A 
 
For NMR structure elucidation, 6.8 mg of curvacin A were dissolved in 750 μl of 350 mM 
deuturated DPC (CDN Isotopes), 10% D2O (Cambridge Isotope Laboratories) and 0.1% 
trifluoroacetic acid. The final concentration of curvacin A in the sample was 2.1 mM. 
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3.8 NMR Spectroscopy of curvacin A 
 
The NMR spectra of curvacine A were obtained at 25oC, 30oC and 35oC on an 800 MHz Varian 
INOVA 800 NMR spectrometer with 4 channels and 5 mm 1H {13C, 15N} pfg probe. TOCSY 
[112] and NOESY [113, 114] experiments included in the biopack were performed to assign the 
molecule. Spectra with mixing times of 48 and 64 ms were acquired for the TOCSY pulsesequence 
and 100 and 150 ms were acquired for the NOESY pulsesequence. Watergate water decoupling was 
applied in the TOCSY and NOESY experiments [115]. 1024K complex data points where obtained 
in the direct dimension and 512 in the indirect dimension. A sinbel function was applied to data and 
it was zero-filled to the double size prior to Fourier transformation. All post processing was obtained 
with the application of NMR Pipe [116], while spectral assignments and integration were done with 
the application of SPARKY (T. D. Goddard. and. D. G.Kneller, University of California, San 
Francisco). NOE restrictions were obtained from the structure assignment of the molecule. 
 
3.9 Restraints and structure calculation 
 
Dihedral angle restraints were obtained by using the TALOS program [117] on the chemical shifts 
values. The NOESY spectrum of the molecule was manually assigned using standard methods [114]. 
A total of 567 NOE distance constrains were obtained after removal of those that can not be violated 
or where found several times, out of which 244 were interresidue and 323 were intraresidue NOE 
restraints. 24 long-range NOE restrains distances larger than 5 residues were observed. The structure 
was calculated and annealed by the application of the structure calculation program CYANA and the 
anneal function. After several rounds of calculations, 6 hydrogen bonds (E21 to S25, I31 to A35, 
S32 to S36, G33 to G37, W34 to L38 and A35 to A39) were introduced in the final annealing of the 
structure. 
 
A total of 100 structures were calculated out of which the 20 best structures were selected for further 
evaluation. The target function gave an average of 1.71·10-2±9.43·10-3. The structures were 
visualized with the MOLMOL program [118].  
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4 Results and Discussion: 
 
4.1 Growth and purification of curvacin A: 
 
4.1.1 Purification of curvacin A from complex culture media 
 
Curvacin A was purified by chromatography on a SP-Sepharose Fast Flow cation exchange column 
followed by chromatography on a RESOURCE RPC column (Figure 4.1.1A), all according to the 
purification method developed by Uteng et al. [109].  
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Figure 4.1.1: A Chromatogram resulting from purification of curvacin A on a 3 ml RESOURCE RPC column using the 
Äkta-system. The blue line is absorbance recorded at 280 nm (left vertical axis) whereas the black line shows the linear 
gradient of 2-propanol (v/v), 0.1% (v/v) TFA used to eluate curvacin A (right axis). Both absorbance and concentration 
were recorded as a function of ml eluent. B Chromatogram resulting from analytical analysis of purified curvacin A on a 
μRPC C2/C18 SC.2.2/110 column using the SMART-system. C Mass spectrum of purified curvacin A obtained by MS-
MALDI TOF.  
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Chromatogram obtained by purification on the RESOURCE PRC reverse phase column using an 
Äkta purifier (Amersham Pharmacia Biotech) is presented in Figure 4.1.1A. The bacteriocin 
appeared as a major optical density peak upon reverse phase chromatography. The chromatogram in 
Figure 4.1.1A shows that curvacin A eluted when the concentration of 2-propanol reached 42%.  
 
The purity of the fractions of curvacin A was subsequently analysed by reverse phase 
chromatography as described in section 3.4 and by mass spectroscopy as described in section 3.5. 
The chromatogram obtained upon chromatography using an analytical (μRPC C2/C18 SC.2.2/110) 
reverse phase column, is shown in Figure 4.1.1B. Figure 1.4.1B verifies the purity of the fractions 
obtained from reverse phase chromatography shown in Figure 4.1.1A as curvacin A eluated as the 
only major optical density peak (Figure 4.1.1B).  
 
To ensure that the molecule in the purified sample was curvacin A and to verify the purity of the 
sample, the molecular mass of the peptide in the sample was determined by mass spectroscopy using 
a MALDI TOF-MS (Figure 1.4.1C). The molecular mass determined was in agreement with the 
theoretical molecular mass of curvacin A as calculated from the amino acid sequence. The mass 
spectrum also revealed that the two cysteines were covalently bonded in a disulfide bridge (the 
observed molecular mass is 2 Da lower than what would be expected if the cysteines were not 
bonded). The fact that the isolated peptide was active and that there is a great loss of activity under 
reducing conditions (where the disulfide bridges are no longer present in the molecule) [14] supports 
this conclusion. From this we concluded that the sample was pure, and that the purified molecule 
was curvacin A. 
 
The overall yield of curvacin A from the overnight cultures was determined by measuring the 
absorbtion spectrophotometrically at 280 nm and using the equation 
 
A= εcl, 
 
where A is the absorbtion measured, ε is the molar extinction coefficient (13940 M-1cm-1 for 
curvacin A), c is the concentration of the sample (the unknown parameter in our experiments) and l 
is the travelling path of the light (1 cm in these experiments). The purified fractions of curvacin A 
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from a known volume of starter culture were measured. From this, the yield was calculated to be on 
average 0.5 mg curvacin A per litre of starter culture. 
 
A drawback of using the method described above to produce curvacin A is that production of 
labelled curvacin A is not practical. Molecules labelled with 13C and/or 15N may markedly simplify 
the NMR-spectra analysis (such as resonance assignment and subsequent structure calculation) [96]. 
Additional information from chemical shift, spin couplings and relaxation behaviour may 
furthermore be obtained by heteronuclear experiments [96]. The development of a procedure for 
producing labelled curvacin A was consequently attempted, and is described in the following 
section. 
 
4.1.2 Over-expression of curvacin A in E. coil-cells 
 
The curvacin A gene was introduced into an over-expression system as described in section 3.1 [48, 
119]. The mutations of the methionines and the transformation into E. coli DH5α-cells were 
successful (data not shown). During the subsequent transformation into E. coli BL21(DE3)pLysS-
cells for protein expression, we encountered unforeseen problems. Several trials of transformation 
were performed, where point-mutations from cysteine-encoding codons to stop-encoding codons, 
and loss (or partial loss) of the incorporated histag were among some of the problems encountered 
(data not shown). Due to these unforeseen problems, this track was abandoned. The procedure has 
successfully been reported for similar bacteriocins [37], and the source of our problems have not 
been identified. Instead, curvacin A was purified as described in 4.1.1 above. This was by-and-large 
done to ensure that a NMR- sample could be obtained within the allotted time. 
 
Recently, the fusion gene of  the lactococcin G α/β gene and the immunoglobuline-binding domain 
gene of streptococcal protein G (GB1 domain) was introduced into E. coli (Per Rogne, personal 
communication), by using a recently developed expression system [120, 121]. The yield of fusion 
protein was high (Per Rogne, personal communication). The fusion protein was then cleaved with 
CNBr, yielding a mixture of the mature peptide and the GB1-domain. The mature peptide and the 
GB1-domain were separated by reverse phase chromatography. The purified labelled bacteriocin has 
since been analyzed by NMR (Per Rogne, unpublished results). 
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For future production of labelled curvacin A and/or other pediocin-like bacteriocins for NMR-
studies, the development of this expression system should be pursued.  Due to the methionine 
residues, an alternative cleavage procedure must however be applied for curvacin A or alternatively, 
the methionine residues in curvacin A may be mutated (see section 3.1 for details) [122]. 
 
4.2 Analysis of curvacin A using CD-spectroscopy 
 
 As mentioned in the introduction, pediocin-like bacteriocins are unstructured in water, but become 
structured upon interaction with membrane-mimicking entities such as DPC. To determine at what 
conditions we have optimal structuring of curvacin A (peptide:micelle-ratio and temperature), 
curvacin A-structuring was investigated by the use of CD-spectroscopy at various temperatures and 
concentrations of DPC-micelles (Figure 4.2.1).  
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Figure 4.2.1 CD-spectra of curvacin A. Mean residual ellepticity (MRE) is plotted as a function of wavelength measured 
in nm. The concentration of curvacin A was fixed at 0.15 mg/ml. A Curvacin A dissolved in DPC at concentrations 
varying from 0 mM to 16 mM at 20oC. B Curvacin A dissolved in 8 mM DPC analysed for structuring at different 
temperatures.   
 
 
Characteristic CD-spectra for α-helices have negative peaks at about 208 and 222 nm and a positive 
peak at about 192 nm [102, 123].  Figure 4.2.1A reveals that curvacin A attains α-helical-structuring 
upon interacting with DPC-micelles. Curvacin A is unstructured at 0 mM DPC, but becomes 
structured at DPC concentrations above the critical micelle concentration of 1 mM (the minimum 
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concentration of DPC in a solution if micelles are to be formed). Already at a DPC concentration of 
2 mM, curvacin A displayed a CD-spectrum with characteristics typically found for α-helices. At 
about 8 mM DPC, the increase in the helical content of curvacin A comes to a rest within the 
uncertainty of the experiment (Table 4.2.1). Evidently, maximum structuring is achieved at 8 mM 
DPC, at the given concentration of curvacin A (0.15 mg/ml, equivalent to 3.5*10-2 mM), with 27-29 
% helicity [110] (See section 2.2.1 for equation that determines % helicity from CD-spectra). This 
corresponds to 11-12 amino acid residues in helical conformation. 
 
There is equilibrium between free peptide (P) and micelles (M) on one hand, and peptide bound to 
micelles (PM) on the other hand: 
 
P + M ↔ PM.  
 
The high concentration of micelles drives the equilibrium towards the bound state of peptide and 
micelle (PM), and hence structured peptide. It appeared from the CD-studies that at 8 mM DPC, 
curvacin A (at a concentration of 0.15 mg/ml) had close to optimal structuring (Table 4.2.1A). That 
is, most of the peptide is structured and associated with micelles. Higher micelle-concentrations 
would drive the equilibrium further towards the bound state. However, the marginal changes in 
structuring of curvacin A at higher concentrations of DPC would probably not produce changes in 
the NMR-signal (the % of structured peptide is at 8 mM already close to 100). Thus a concentration 
of 8 mM DPC was chosen for further CD-experiments. 
 
In Figure 4.2.1B, 0.15 mg/ml curvacin A dissolved in 8 mM DPC has been titrated at temperatures 
from 15 oC to 45 oC. At all temperatures, the CD-spectra were typical for α-helical peptides. At 
higher temperatures (40 oC and 45oC), however, a loss of structuring was observed. This was 
especially pronounced in the area around 200-210 nm, where the intensity of the negative peak 
decreased. This indicates loss of secondary structure, possibly due to thermal instability of the three-
dimensional structure. In the temperature range between 25 oC and 35oC, curvacin A has a stabile α-
helical content, and the curves are equal within the uncertainty of the experiments. 
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Table 4.2.1 Statistical data from CD-spectroscopy of curvacin A. A Correlation between micelle concentrations and  
secondary structure of curvacin A [110, 111]. The peptide:micelle-ratio for the corresponding concentration of DPC is 
shown. Experiments performed at 20oC B Correlation between increased temperature in a sample with constant 
concentration of  DPC = 8 mM and secondary structure of curvacin A [110, 111]. The concentration of curvacin A is 
fixed at 0.15 mg/ml throughout the experiments. 
A                                                                                          B 
DPC in 
mM at 
20oC 
Peptide:micelle-ratio 
at different DPC 
concentrations 
% α-helical content  
of curvacin A 
 Temperature in oC of 
curvacin A in 8 mM DPC 
% α-helical content  
of curvacin A 
    20 27 
0 ∞ 4.5  25 30 
1 2 23  30 29 
2 1 23.5  35 27.5 
4 0.5 24.5  40 26 
8 0.25 27  45 25 
12 0.15 29  50 24 
16 0.1 29  55 23 
 
 
Under the conditions of the CD-experiments above, DPC forms spherical micelles [124, 125]. 
Molecular modelling has shown that an average of 54 molecules of DPC form one micelle [124]. 
The relative amounts of peptide and DPC in the CD-experiments, shows that a peptide:micelle-ratio 
≤ 0.25 is needed for optimal structuring when the DPC is ≥8 mM. The relative large amount of DPC 
compared to curvacin A needed to obtain optimal structuring suggests that a molecule of curvacin A 
is not permanently associated with a particular micelle, but rather fluctuates between a micelle-
associated structured state and an unstructured state.  
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4.3 NMR structure calculation of curvacin A 
 
For a NMR-sample, several mg of curvacin A are necessary to obtain good spectra. Here, 6.8 mg of 
curvacin A in a total sample volume of 140 μl was used. From the CD-experiments we found that 
the DPC concentration had to be ≥8 mM, and that the peptide:micelle-ratio should be ≤ 0.25 for 
optimal structuring. Thus, for a 140 μl sample containing 6.8 mg curvacin A, a micelle concentration 
of about 350 mM DPC would give a peptide:micelle-ratio of 0.25. Hence, for the NMR-sample 
preparation, 6.8 mg curvacin A was dissolved in 350 mM DPC (see section 3.7). Temperatures 
between 25 and 35 oC were chosen for NMR-experiments, based on the results of the CD-
experiments. 
 
Several NMR spectra, both TOCSY and NOESY, of curvacin A were recorded at temperatures of 
25, 30 and 35oC. The mixing times were 48 ms and 64 ms for the TOCSY spectra, whereas the 
NOESY spectra had mixing times of 100 ms and 150 ms. By inspecting spectra recorded at different 
mixing times and temperatures, we found that the most optimal spectra with respect to resolution and 
number of well-defined peaks were obtained at 35oC with a mixing time of 48 ms for TOCSY and 
150 ms for NOESY. These were consequently the spectra that were used the most, although 
additional information was obtained from spectra recorded under different conditions. 
 
There are several protocols that thoroughly describe the processes involved in analysing NMR 
spectra obtained by different types of NMR techniques [80, 94, 96]. The procedure applied in the 
structural assignment of curvacin A was described in sections 2.1.7.1 (interpretation of TOCSY 
spectra) and 2.1.8.1 (interpretation of NOESY spectra). In the following, the analysis of the NMR 
data obtained on curvacin A is presented.  
 
Curvacin A consists of 41 amino acids, where all but the first (A1) amine proton are potentially 
visible in the spectra recorded. The amine protons of the first residue in a polypeptide chain cannot 
readily be observed because the free amine protons are in fast exchange with the protons of the 
solvent molecules: one proton is exchanged for another in too short a time for a signal to be detected 
[80, 86]. The remaining 40 amino acids are divided between 12 different spin systems. Table 4.3.1.1 
below shows the distribution of amino acids between these spin systems. 
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Table 4.3.1.1: Distribution of spin systems among the amino acids in curvacin A 
Spin system 
 
Associated amino 
 acids in curvacin A 
Number of amino 
 acids in curvacin A 
AMX S, C, N, Y, W 13 
AM(PT)X Q, E, M 3 
A2(T2)MPX R 2 
A2(F2T2)MPX K 2 
A3B3MX V 2 
A3MPT(B3)X I 3 
A3B3MPTX L 1 
A3MX T 1 
AX G 8 
A3X A 4 
AA'XX' Y: ring protons 2 
A(X)MP+A W: ring protons 2 
 
 
 
RESULTS AND DISCUSSION 
 52
8.5 8.0 7.5
4.5
4.0
3.5
3.0
2.5
2.0
1.5
AMX
AMX
MPXγ
β
δ
α α
β
α
β
β
γ
β
δ
α
w2 -
1H (ppm)
w
-1 H
 (p
pm
)
1
Fig
Figure 4.3.1.2: Identification of three spin systems in 
the (35oC/48 ms) TOCSY spectrum of curvacin A. 
The peaks are labelled according to the carbon atom 
with which the hydrogen atoms are bonded. The red 
line connects a MPX spin system, whereas two AMX 
spin systems are connected with pink and green lines, 
respectively. See text for details.
 
From the principles described in Figure 2.1.7.1, we can in Figure 4.3.1.2 identify three different 
spin-systems. The red, pink and green lines connect three different spin systems. The pink AMX 
system shows a markedly lower ω2-shift compared to the green system, which is most pronounced 
for the pair of β-protons. This is typical for a serine residue. The green AMX system is compatible 
with any of the amino acids associated with an AMX spin system. 
 
The red spin system has unique topology with respect to the two other spin systems that are labelled 
in Figure 4.3.1.2. The A2(T2)MPX (MPX for short) can only be one amino acid in curvacin A: 
arginine (Figure 4.3.1.3). This spin system can therefore be assigned to either R2 or R19.  
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Figure 4.3.1.3: Illustration of the amino acid arginine, highlighting the two amine groups in arginine (purple circles) that 
correlates to the other side chain protons in Figure 4.3.2.1. 
 
The uniquely recognizable spin system of arginine consists of what appears to be the two parallel 
spin systems along the ω2-shift in the amide region. These two parallels are marked with red vertical 
lines in Figure 4.3.1.2. The horizontal red lines connect the cross peaks between the same side chain 
protons (α, β, γ or δ) and different amine (side chain)/amide (backbone) proton. The only difference 
between the two parallels is which proton they correlate to. The R-side chain of arginine contains a 
guanidine group (Figure 4.3.1.3), and thus the one and same spin system correlates to different 
nitrogen-bonded protons in the amino acid in this region. In this case, correlations from the 
backbone amide proton (far right of Figure 4.3.1.3) and from the side chain guanidine group-proton 
in pink circle in Figure 4.3.1.3 (far left of Figure 4.3.1.2) can be seen. Also, the δ-peak around 3 ppm 
is typical for this type of spin system. This proton is connected to the side chain amide group, and 
has a much lower chemical shift value than typically observed for other δ-protons.  
 
The lysine residues exhibit the same peak topology as the arginine residues, with an additional side 
chain proton peak at around 1.5 ppm (lysine has four side chain carbon atoms) (see Figure 2.1.1.1). 
Lysine has an amino group in the ζ-position of the side chain, and thus the side chain protons 
correlates to two different amide protons in the same manner as described for arginine. The two 
lysine residues were therefore easily recognizable from the TOCSY spectrum. Thus, if one locates a 
cross peak at about 3 ppm that is connected with cross peaks at higher ppm in a TOCSY spectrum, 
this is indicative of either a lysine or an arginine residue. 
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Figure 4.3.1.4 Correlation between the ring protons, amide proton and β-protons of Y4. The peaks are labelled as 
described in section 2.1.7, with QD and QE representing the (2, 6) and (3, 5) ring proton pairs, respectively. Horizontal 
and vertical black lines connecting the cross peaks are added for clarity. 
 
The aliphatic side chains of the aromatic residues in curvacin A can be singled out by identifying 
which AMX-spin systems correlates with the ring protons. The ring protons are positioned in the 
spectral region around the diagonal at about 6.7-7.5 ppm. Cross peaks between the ring protons and 
the α- and/or β-protons connects the aliphatic protons and the ring protons in one spin system with 
unique topology. Locating the aromatic residues in the NOESY spectrum alleviates the sequential 
assignment procedure described in section 4.4, as there are few aromatic residues in curvacin A. This 
reduces the number of possible positions of these residues in the sequence, and the proximate 
residues linked up to the aromatic residues. In Figure 4.3.1.4, this is done for the ring protons, the 
amide proton and the β-protons of a tyrosine residue (subsequently identified as Y4). The α-proton 
is left out for clarity as the peak is partly buried in the water peak. 
 
The cross peaks between the side chain protons and the amide proton at the far left of Figure 4.3.1.4 
are the same cross peaks as the green AMX-spin system in Figure 4.3.1.2. Thus, the green AMX-
spin system must belong to one of the two tyrosine residues (Y4 or Y9). 
 
 
RESULTS AND DISCUSSION 
 55
4.3.2 Overlapping peaks and signal-to-noise: 
 
Even though it in theory should be simple to analyse a spectrum, the interpretation of a spectrum 
may be difficult. The HN-shift values of L38 (7.867) and A39 (7.862) for example are close, and 
differentiating between the two spin systems can thus be difficult. All the backbone amide protons in 
curvacin A resonate between 8.7 and 7.6 ppm at 30oC. That is 40 spin systems within a range of 1.1 
ppm. With this high density of peaks, overlapping peaks complicate the analysis.  
 
The region between 4.3 and 3.7 ppm is very crowded (Figure 4.3.2.1). In this region we find the Hα-
HN cross peaks along with the Hβ-HN cross peaks from serine and threonine residues. For example, 
the α-proton peaks belonging to G40 (coordinates 8.045, 3.955) and G29 (coordinates 8.048, 3.942) 
are clustered together in what appears to be one single peak. Sequential determination (as described 
in section 4.4) revealed that two proton peaks (G29-Hα1 and G40-Qα ) were positioned very close 
to each other (intra residue cross peaks going to both M30 and M41 went from this position, 
indicating that both G29 and G40 had a proton located at this shift). 
 
The region between 4.3 and 3.7 ppm is in addition close to the resonance of the water protons, which 
creates noise that complicates the assignment of this part of the spectrum. As can be seen from 
Figure 4.3.2.1, Y4- and W34 -HA-HN peaks are just on the edge of the ridge, making identification 
of these peaks difficult. 
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Figure 4.3.2.1 Section of the (150 ms/35oC) NOESY spectrum showing the crowded region with correlation between the 
α-protons and the amide protons. The peaks are labelled with one-letter code for residue-type and -number according to 
the position in the sequence, together with the correlated spins giving rise to the cross peak. 
 
Correlations of the same spin systems as in Figure 4.3.2.1 can be found in the alkyl region (see 
Figure 2.1.7.1 for definition). Here, the correlation from one of the side chain protons in the residue 
to the other protons is visible. Spin systems that have overlapping HN-shifts may have well-
separated e.g Hα-shifts, and one can thus separate two spin systems from each other. By employing 
all the spectral regions in a NMR-spectrum (fingerprint- amide- and alkyl-region) many ambiguities 
due to overlap in certain regions can be overcome. The cross peaks in a NMR-spectrum are reflected 
about the diagonal (see Figure 2.1.8.1), as a result of the direction in which the magnetisation 
travels. An area with much noise on one side of the diagonal may have a complementary area with 
less noise on the opposite side of the diagonal. Peaks that are not well defined on one side of the 
diagonal may thus be well-defined on the opposite side. By tracing complementary peaks on both 
sides of the diagonal, the identification of these peaks becomes easier. 
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4.3.3 Spectra recorded at different temperatures and with different mixing times 
 
By changing the temperature at which a spectrum is recorded, the position of the water signal 
changes. The chemical shift of water varies linearly with temperature: 
 
Chemical shift of water (ppm) = 4.766 ppm – (0.0119 ppm oC-1)(temperature in oC - 25 oC) [87] 
 
The chemical shift of water is thus highly correlated to temperature. A peak that is buried in the 
water peak at one temperature can be well separated from the water peak at a different temperature. 
As an example, the N18Hα-peak (coordinates 8.374, 4.627) is buried in the water ridge in the 35oC 
TOCSY spectrum (Figure 4.3.2.1). The peak could be identified by inspecting another spectrum 
recorded at 25 oC, where the water ridge and the N18Hα-peak do not overlap. 
 
The binding of peptide to the micelles is temperature-dependant. There is equilibrium between two 
different states of the peptide: bound to micelles (structured) and free peptide (unstructured). The 
interconversion between the two states is in fast exchange, and the population of the unstructured 
state is low compared with the structured state (CD-results indicate that majority of curvacin A 
molecules are associated with micelles, and that only a small fraction of peptides are not bound to a 
micelle (unstructured) at at a given time). As a result only one narrow peak is seen in a spectrum. 
This peak reflects the average of the two structures (bound and free peptide). The equilibrium 
conditions are temperature dependant. Thus, by changing the temperature, there is a shift in 
equilibrium between the two states (the population of the two states changes with respect to each 
other as a result of the change in the equilibrium conditions) and as a result, the peaks in a spectrum 
may move. Peaks from different protons that overlapped in one spectrum can be separated at another 
temperature because the change in temperature affects the equilibriums and causes the two proton 
peaks to move relative to each other in the spectrum. Changing the temperature does not change 
which protons correlate with each other. Thus, one can distinguish between two overlapping spin 
systems by noting which peaks move together when the temperature is changed. For example, in the 
35 oC spectrum, the amide shift of S3 and N12 overlap at 8.34 ppm. In the 25 oC spectrum, however, 
these two spin systems are well separated at 8.36 (S3) and 8.42 (N12) (Figure 4.3.3.1). 
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Figure 4.3.3.1 TOCSY spectrum at 35oC/64 ms (left) 
and TOCSY spectrum at 25 oC/48 ms (right) of the 
amino acid residues S3 and N12. The N12-spin system 
is connected with a black vertical line in both spectra. 
The two spin systems overlap in the w2-dimension in 
the lefthand (35 oC) spectrum, but are well separated in 
this dimension in the rigthand (25oC) spectrum. 
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4.4 Sequential assignment and dipolar couplings; NOESY 
 
After having identified the different spin systems in the TOCSY spectrum, the next step was to 
determine which systems were connected sequentially. This was achieved by analysing a NOESY 
spectrum. By employing the principles described in Figure 2.1.8.1, three spin systems taken from the 
NOESY spectrum of curvacin A were identified in Figure 4.4.1.  
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Figure 4.4.1: Connections of three spin systems in the fingerprint region of the (35oC/150 ms) NOESY spectrum. See 
text for details. 
 
These are the same three spin systems as in Figure 4.3.1.2. They are connected sequentially as 
described in Figure 2.1.8.1: MPX (residue i) to AMX pink (residue i+1) to AMX green (residue i+2). 
The next step was to determine where in the sequence these three spin systems are positioned. The 
interresidual NOE couplings between the spin systems are labelled by stating which proton on a 
residue contributes to the particular cross peak. For example, the cross peak R2HA-S3HN is the 
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cross peak between the α-proton of R2 and the amide proton of S3. This is already done in Figure 
4.4.1, and the process is described below. 
 
By labelling all the amino acids in the curvacin A sequence according to spin system type, and 
inspecting where in the sequence these three spin systems occur sequentially, one can determine 
which amino acids they represent. The MPX spin system can, as described above, only be an 
arginine. The pink AMX-spin system is most likely a serine, whereas the green AMX-spin system is 
a tyrosine. Thus the three connected spin systems are R (residue 1), S (residue 2) and Y (residue 3). 
There is only one place in the sequence where these three spin systems occur sequentially: R2, S3 
and Y4.  
 
Assuming that the spin systems were not as easily recognizable, one would have had to determine 
the sequential arrangement based on the identification of the spin systems. The two AMX spin 
systems could be either of five amino acids (serine, cysteine, asparagine, tyrosine or tryptophan) 
(Table 4.3.1.1). There are four possible locations for two consecutive AMX-spin systems in the 
curvacin A sequence; S3-Y4, Y9-C10, C10-N11 and N11-N12. It was thus not possible to determine 
which amino acids these two spin systems corresponded to without connecting them up to the next 
and/or the previous amino acid. The two AMX-spin systems follow sequentially after the MPX-spin 
system. As we know that the MPX spin system must be an arginine, the three amino acids could be 
located on one of two stretches along the sequence; R2-S3-Y4 or R19-G20-E21. S3 and Y4 both 
belong to an AMX-type spin system. G20 belongs to an AX-spin system, whereas E21 belongs to an 
AM(PT)X spin system. There was thus only one of these stretches of three amino acids in the 
sequence that fitted the given sequence of spin systems identified in Figure 4.3.1.2, and connected in 
Figure 4.4.1; R2 (residue i), S3 (residue i+1) and Y4 (residue i+2). The same result is thus obtained 
from only analysing the type of spin systems as when the identity of the amino acids is known. It is 
none the less easier to pick out the right sequence if the spin systems are already identified as a 
particular amino acid. Figure 4.4.1 shows how these three amino acids are connected in the lower 
part of the fingerprint region. In Figure 4.4.2, supporting cross peaks between the R2 β-protons and 
S3 amide proton are traced. 
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Figure 4.4.2 Cross peaks between R2 and S3 confirming the sequential assignment as determined in Figure 4.4.1. 
 
The sequential connection of the three amino acids is further confirmed by tracing the amide region 
for cross peaks between backbone amide protons. Ideally, one should be able to locate cross peaks 
on both sides of the diagonal, as shown in Figure 2.1.8. However, the spectral region close to the 
diagonal is crowded with peaks that to a large extent overlap and one can often only identify a 
limited number of these connections with confidence. The NOESY spectrum in Figure 4.4.3 shows 
the backbone cross peaks for R2-S3-Y4.  
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Figure 4.4.3: The three amino acids R2, S3 and Y4 connected by interresidual cross peaks in the amide region of the (35 
oC/150 ms) NOESY spectrum of curvacin A. The black line shows the connections going from Y4 to R2, whereas the 
pink line shows the connection going from R2 to Y4.  
 
Cross peaks from R2-Y4 on both sides of the diagonal are marked in Figure 4.4.3. Between S3 and 
Y4 there is a distinct peak at both side of the diagonal confirming the sequence determined above. 
The connection between R2 and S3 is clearly identified. The pink line shows the connection from R2 
to Y4, whereas the black line shows the opposite direction; from Y4 to R2. 
 
Ideally, connections between all amino acids in a molecule from the first to the last residue should be 
identified through Hα-HN, Hβ-HN and HN-HN (i, i+1) connections. This is seldom possible, as real 
spectra are not always easy to assign. Furthermore, the strength of these connections is structure-
dependant. In Figure 4.4.4, five consecutive amino acid residues in the Hα-HN region were 
identified.  
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Figure 4.4.4 The amino acid residues I27 through I31 connected by interresidual NOE cross peaks in the (35 oC/ 150 ms) 
NOESY spectrum. The first NOE cross peak is between α-proton of I27 and the amide proton of G28. The direction of 
the sequential NOE cross peaks are identified by arrows. 
 
In Table 4.4.1A, the NOEs observed in curvacin A are listed. Sequential connections for all residues 
were identified through Hα-HN, Hβ-HN and/or HN-HN (i, i+1) connections. All residues are 
sequentially linked up to each other by at least one (i, i+1) connection. This verifies that the 
assignment of the spin systems is correct. Multiple connections are especially pronounced in the C-
terminal end of curvacin A, where medium range NOEs are also found. The importance of this is 
discussed in section 4.5 below. 
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Table 4.4.1 A Pattern of interresidue NOEs observed in the NOESY experiment (150 ms mixing time) with curvacin 
A in the presence of 8 mM DPC. The thickness of the lines shown is relative to the size of the NOE cross peak 
intensities. The triangles indicate where TALOS found dihedral angle restrains that are typically found for α-helices, 
stars indicate dihedral angles that can be both α-helix and β-sheet, and circles indicate angles that are found for 
neither helices nor β-sheets. B the CSI indexes [126, 127] obtained by analysis of the Hα and N chemical shift 
values of curvacin A.  
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Table 4.4.2 lists the number of NOEs derived from the (35oC/150 ms) NOESY spectrum of curvacin 
A. There are few long range (R≥5) NOEs. This indicates that the structure of curvacin A is such that 
it does not allow close contact between residues far apart in the sequence. i.e the structure must be 
fairly linear. 
 
 
 
Table 4.4.2 Number of total NOEs (567) for curvacin A 
divided into groups according to the range R between 
the residues. Intraresidual: R=0. Sequential: R=1. 
Medium range: R<5. Long range: R≥5. Number 
hydrogen bonds are listed last. 
Number of NOEs and H-bonds 
Intraresidual 323 
Long range 24 
Medium range 78 
Sequential 142 
H-bonds 12 
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4.5 Structure prediction of curvacin A and input data for structure calculation 
 
Upper distance constraints are the major input data for structure calculation with Cyana. These 
distance limits are generated by Cyana based on the list of integrals or intensities of the NOESY 
peaks and the assignment of these peaks. Upper distance constraints for the known disulfide bridge 
between C10 and C15 is also included in the calculation. These are based on upper distance limits 
between disulfide bridges from other predicted structures [128]. From the input data, predicted 
structural elements of curvacin A are clearly visible. Additional angle constraints from the 
application of TALOS, and constraints for hydrogen bonds between residues in helical 
conformations (as predicted by CSI and early structure calculations) are added in the final 
refinement of the structure calculation. These additional constraints verify and strengthen the already 
predicted structure of curvacin A from earlier calculations. 
 
CSI and TALOS structure prediction 
Information from chemical shift values is of importance in NMR structure calculation, as described 
in section 2.1.1. In this thesis, secondary structure elements (α-helix, β-sheet or random coil) of 
curvacin A is predicted by the use of CSI [84] and TALOS [117]. 
 
In CSI-prediction, the values -1, 0 and 1 are given to every residue in a peptide segment relative to 
whether the 1H-shift is downfield, within or upfield, respectively,  of a given threshold value based 
on the random coil value of that specific residue. Depending on the number of consecutive residues 
with +1, -1 or a mix of the two, the region is ascribed as having α-helical-,  β-sheet- or random coil- 
conformation (a row of three or more 1 indicates β-sheet, a row of four or more -1 indicates α-helix) 
The same prediction can be carried out for 13C-shifts, but with the signs for β-sheet and α-helix 
interconverted [81]. This has proven to be a quick and easy way to confirm already plausible 
structures, or to hint at as of yet unknown structural elements.  
 
TALOS (Torsion Angle Likelihood Obtained from Shift and sequence similarity) is a program that 
calculates the protein backbone angle restraints from searching a database for chemical shift and 
sequence homology [85]. TALOS uses any combination of 13Cα-, 13Cβ-, 13C’-, 1Hα- and 15N-shifts 
tabulated from a given spectrum as input values and gives predicted φ− and ψ−angles for each 
residue. The more shifts added for a residue, the more accurate the output angles calculated. 
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Currently, a string of three consecutive amino acid residues are used to predict the central residue’s 
angles [85], to ensure that the predicted angles also are in agreement with adjacent peptide bond 
angles. 
 
From the TALOS prediction presented in Table 4.4.1A, dihedral angles are overall in agreement 
with an α-helical conformation between residues R19-I27 and G29-A39. The NOE pattern confirms 
the C-terminal helix, with intraresidual NOE couplings between residues i and/or i+3 and i+4 (which 
are typical connections for residues in α-helical conformation). There are two i+3 intraresidual 
NOEs in the region around residues 19-24 indicating a possible central helix. The CSI-prediction in 
Table 4.5.1B is somewhat more ambiguous, but α-helical regions can be identified between residues 
A21-S25 and M30-S36 (only one interruption of consecutive -1’s). No secondary structure elements 
could be predicted for the N-terminal part of curvacin A from these results. Thus, from the 
preliminary structure prediction of curvacin A one can conclude that an unstructured N-terminal 
region is followed by a possible central helix, and a C-terminal helix. 
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Figure 4.4.5 Edmundson helical wheel of fragments of curvacin A (A and B), carnobacteriocin BM1 (C and D) and 
enterocin P (E and F). Colour-scheme referres to polarity and numbers to residue number in bacteriocin sequence. A, C 
and E helical wheel representation of the central (polar) helix. B, D and F helical wheel representation of the 
amphiphilic C-terminal helix. 
 
Helical wheel analysis 
Edmundson helical wheel analysis of curvacin A, carnobacteriocin BM1 and enterocin P (Figure 
4.4.5) reveals that all can form a central polar helix and an amphiphilic C-terminal helix. The short 
central polar helix (residues 18-25 for curvacin A, 18-24 for carnobacteriocin BM1 and 21-26 for 
enterocin P) is only interrupted by the mildly hydrophobic amino acid alanine (Figure 4.4.5A, C and 
E). In addition, enterocin P may form a central amphiphilic helix between residues 19 and 27 (Figure 
4.4.5E). The amphiphilic C-terminal helix (residues 25-41 for curvacin A, 30-43 for 
carnobacteriocin BM1 and 26-44 for enterocin P) has a wide hydrophobic side and a narrow 
hydrophilic side (Figure 4.4.5B, D and F). However, both curvacin A and carnobacteriocin BM1 
have a double glycine-motif (G28-G29 for curvacin A, G32-G33 for carnobacteriocin BM1) that is 
not expected to be in a secondary structural element such as an α-helix. The double glycines 
introduce flexibility to the structure, and therefore an amphiphilic helix might be formed between 
residues 29-41 (curvacin A) and 33-43 (carnobacteriocin BM1). No such double glycine-motif is 
found for enterocin P. 
4.6 Three-dimensional structure of curvacin A as predicted with CYANA 
 
From a total of 567 NOEs, calculations with CYANA and the ANNEAL-routine of CYANA, 20 
final structures of curvacin A in DPC micelles were generated. Table 4.6.1 presents some statistical 
data derived from this calculation. 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
 69
Table 4.6.1 Statistical data from the structure prediction 
of curvacin A in DPC-micelles. A Deviation from 
dihedral angles found in secondary structure elements 
as described in a Ramachandran-plot. B The global root 
mean square distances measured for the calculated 
ensemble of 20 curvacin A structures by the application 
of the MOLMOL program [118] 
 
 
A 
Ramachandran deviation (%)* 
Most favoured 63.2 
Additionally allowed 19.5 
Generously allowed 12.9 
Disallowed 4.4 
 
 
B 
Global Root-Mean-Square-Difference (RMSD) in Å** 
Residues Backbone*** All atoms Residues Backbone** All atoms 
1-41 6.56±1.88 7.52±1.95 18-24 1.09±0.71 2.56±1.11 
2-15 1.99±0.69 2.82±0.79 19-24 0.63±0.39 1.89±0.67 
2-16 2.28±0.89 3.06±0.96 19-25 0.70±0.35 1.91±0.64 
2-17 2.62±1.02 3.38±1.10 20-24 0.28±0.14 1.18±0.28 
3-15 1.96±0.72 2.76±0.83 28-39 0.37±0.23 0.58±0.20 
3-16 2.21±0.87 2.97±0.97 29-39 0.18±0.08 0.52±0.18 
3-17 2.49±0.91 3.23±1.13 29-40 0.23±0.10 0.54±0.19+ 
19-39 2.75±1.03 4.37±1.46    
*Calculated with PROCHECK [129]  
**Calculated with MOLMOL[118] 
***N, Cα and C
 
Table 4.6.1A lists the percentage of dihedral angles that are within allowed regions for known 
secondary structure elements for proteins (α-helix, β-sheet and random coil). Only 4.4% are located 
in disallowed regions, indicating that the calculated structure is a plausible structure from a stereo 
chemical point of view. Table 4.6.1B lists RMSD-values for various superimpositions of the 
structure of curvacin A. A low RMSD with a low uncertainty is consistent with similar structure in 
the given region for all 20 calculated structures (and therefore a structured region). From these 
statistics, three structural regions can be identified: the first between residues 2-16, the second 
between residues 19-24 and the third between residues 29-39. Figure 4.6.1 shows the peptide 
backbone of the 20 final structures of curvacin A superimposed on these three regions along with a 
superimposition over the entire molecule. 
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A C
B D
Figure 4.6.1 Superimposition of the 20 final peptide backbone structures of curvacin A. A Superimposition over entire 
molecule (residues 1-41), B Superimposition over residues 2-16, C Superimposition over residues 19-24 D 
Superimposition over residues 29-39. Figure prepared with the program MOLMOL [118]. 
 
The three structural regions in curvacin A are all clearly observable from Figure 4.6.1: A S-shaped 
or β-sheet-like domain N-terminally (B), a short central α-helix (C) and a longer C-terminal α-helix 
(D). The superimposition over the entire molecule (A) shows that the three regions are flexible 
relative to each other. Evidently, there are two hinge regions in curvacin A: one between the β-sheet-
like domain and the central α-helix (residues 16-18) and another between the two helices (residues 
25-28). The short C-terminal tail (residues G40 and M41) is unstructured. 
 
The N-terminal domain is less ordered than what has been observed for sakacin P and leucocin A. 
However, it is more structured than what was observed for carnobacteriocin B2. It was not possible 
based on the experimental data to assign a perfect β-sheet structure to this domain, although the S-
shape indicates a β-sheet-like structure. The β-sheet like structure contains two loops forming an S-
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shape. The first loop spans residues 2-10, whereas the second loop runs from residue 10 to 15. 
Medium range NOEs from R2, S3 and Y4 to V8 and Y9 ties the N-terminal tail up to the second 
loop of the β-sheet like structure. The cysteine bridge between residues C10 and C15 ties the C-
terminal part of this domain covalently together with the starting point of the second loop. The two 
α-helices are well-defined, as can be seen from Figure 4.6.1. The C-terminal helix is at an angle with 
respect to the central helix. By close examination of the helices and the side chains of the 
participating amino acid residues, the central helix was found to be a hydrophilic polar helix (A22 is 
the only non polar amino acid residue in this helix, and the short side chain of alanine will not 
contribute markedly with hydrophobicity) (Figure 4.6.2), whereas the C-terminal α-helix was found 
to be amphiphilic (Figure 4.6.3) 
 
ARG 19
GLU 21
ALA 22 GLN 24
THR 23
ARG 19
ALA 22GLU 21
GLN 24 THR 23
A B
 
 
Figure 4.6.2 Peptide backbone representation of curvacin A with the side chains of residues 19-24. A Residues 19-24 
Residue 20 is a glycine, therefore no side chains are visible for this residue. Polar side chains are coloured red, non polar 
side chains are coloured green. B As in A, but seen down the axis of the helix from R19 to Q24. Figure prepared with the 
program MOLMOL [118]. 
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Figure 4.6.3 Peptide backbone representation of curvacin A with side chains of residues 30-39. A Residues 29-39 of 
curvacin A with non polar side chains in green and polar side chains in red. Residues 29, 33 and 37 are glycines, 
therefore no side chains are visible for these residues. B As in A, but seen down the axis of the helix from G29 to A39. 
Polar side chains point up and non polar side chains point down. Figure prepared with the program MOLMOL [118]. 
 
The non polar green residues in Figure 4.6.3B all point in the same direction (downwards in the 
figure), whereas the polar red residues point in the opposite direction. This indicates an amphiphilic 
helix, with all the polar residues on one side of the helix and all the non polar residues on the other 
side of the helix. Figure 4.6.4 shows a cartoon depiction of the three-dimensional structure of 
curvacin A, with the three regions described above. 
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Figure 4.6.4 Cartoon depiction of the three-dimensional structure of curvacin A in DPC-micelles. 
 
4.7 Implications of the NMR-structure on the classification of curvacin A and 
its mode of action 
 
In addition to the structure of curvacin A presented in this thesis, the structure of one other group 3 
pediocin-like bacteriocins has been reported: carnobacteriocin B2 [54]. Unlike group 1 (structure 
solved for sakacin P) and group 2 (structure solved for leucocin A) pediocin-like bacteriocins, 
sequence alignments between curvacin A and carnobacteriocin B2 does not show large similarities 
(Figure 2.1.1). The structures of these two group 3 pediocin-like bacteriocins are also substantially 
different. The structural and sequential differences between curvacin A and carnobacteriocin B2 
opens for discussions as to whether or not these two bacteriocins should be placed in the same group 
[130]. By comparing the amino acid sequence of the group 3 pediocin-like bacteriocins, it might be 
more relevant to place curvacin A, carnobacteriocin BM1 and enterocin P in one group, and 
carnobacteriocin B2 and bacteriocin 31 in another, as the three former peptides have similar 
sequence (especially in the C-terminal half) which is different from the sequence of carnobacteriocin 
B2 and bacteriocin 31 (Figure 2.1.1).  
 
The three-dimensional structure of the group 3 pediocin-like bacteriocin curvacin A differs from the 
structures reported for group 1 and 2 pediocin-like bacteriocins. The two helices in curvacin A 
makes the proposed positioning in the membrane for group 1 and 2 not plausible for curvacin A. An 
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α-helix has to be approximately 20 amino acid residues long to span a bilayered membrane [131]. 
The C-terminal α-helix of curvacin A is only 11 residues long and thus cannot span the membrane 
(as is also the case for group 1 and 2). It is however possible that it penetrates into the membrane-
surface interface, and that the C-terminal helix of curvacin A thus has a function equivalent to that of 
the hairpin-like structure of group 1 and 2 pediocin-like bacteriocins. The polar central helix is not 
likely to be associated with the hydrophobic part of the membrane, but would rather remain on the 
outer side of the membrane. The N-terminal domain is also most likely to remain on the outer side of 
the membrane (possibly associated with a receptor molecule). A possible alternative positioning is 
presented in Figure 4.7.1. The two helices and the β-sheet like domain are moved relative to each 
other at the hinges compared with Figure 4.6.4.  
 
Hydrophilic outer side of membrane
Hydrophobic core of membrane
Membrane-surface interface
 
Figure 4.7.1 Possible orientation of curvacin A in a membrane 
 
Activity assays show that the methionines are important for the activity of curvacin A [28]. 
Oxidation of the methionine residues (M30 and M41), particularly M30, was shown to reduce the 
activity 10- to 100-fold. This indicates that M30 is important for the activity of curvacin A, and is 
possibly more deeply buried in the membrane than M41 (not shown in Figure 4.7.1). Solid-state 
NMR techniques can be applied to verify how curvacin A position itself in the membrane [132-136]. 
The relative orientation between the peptide and the membrane can be elucidated as the peptide is 
motionally restricted in solid-state. Fluorescence-studies of the tryptophan-residues may reveal how 
deep these residues are buried in a membrane [137], which again indicates the molecule’s position in 
the membrane.  
 
In vitro site-directed mutagenesis of amino acids in the hinge regions and the two helices may 
provide valuable information about what kind of conserved residues are important for the activity of 
curvacin A (conservation of hydrophobicity/hydrophilicity, charged/aromatic residues etc) [57, 107]. 
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From the sequence comparison of different pediocin-like bacteriocins shown in Figure 2.1.1, it is 
believed that the structure of the curvacin A, enterocin P and carnobacteriocin BM1 have the same 
overall structure as their sequences are similar. 
 
Finally, it is not only the sequences (and thus possibly the overall structure) of the curvacin A, 
enterocin P and carnobacteriocin BM1 that are very similar. Also the sequences of the immunity 
proteins of these bacteriocins are similar, while the immunity protein of carnobacteriocin B2 has 
quite different sequence [138]. The immunity proteins are thought to specifically recognize the C-
terminal domain of the pediocin-like bacteriocins (the hairpin domain of group 1 and 2 pediocin-like 
bacteriocins) [27], and that the structure of the bacteriocin is important for recognition by the 
immunity protein. The immunity proteins of curvacin A protect against enterocin P and visa versa 
[138], indicating that their structure is similar (at least the C-terminal domain that is recognized by 
the immunity protein). It would be interesting to test whether or not carnobacteriocin BM1 also 
shares immunity against the other peptides. 
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5 Concluding remarks 
 
The three-dimensional structure of curvacin A in DPC micelles has been determined by the use of 
NMR-spectroscopy. The molecule has an S-shaped N-terminal domain supported by a disulfide 
bridge, followed by two helices in the C-terminal half. The central helix is short and polar, whereas 
the C-terminal helix is longer and amphiphilic. There is a hinge between the S-shaped N-terminal 
domain and the central helix and a hinge between the central helix and the C-terminal helix, and this 
enables the three regions to move relative to each other The helix-hinge-helix structure found in the 
C-terminal half of curvacin A is quite different from the hairpin-like structure found for sakacin P 
(group 1) and leucocin A (group 2), indicating that the group 3 pediocin-like bacteriocins might have 
a somewhat different mode of action and position in the membrane than what has been found for 
group 1 and 2. The C-terminal structure of the group 3 bacteriocins enterocin P and carnobacteriocin 
BM1 is believed to be equivalent to the one observed for curvacin A, based on sequence similarities.  
  
The structure of curvacin A differs markedly from the structure found for carnobacteriocin B2 
(another group 3 pediocin-like bacteriocin). On the basis of this and their amino acid sequence, it 
might be relevant to separate the group 3 bacteriocins curvacin A, enterocin P and carnobacteriocin 
BM1 from the rest of the bacteriocins in this group. Other, as of now, unknown structures of group 3 
pediocin-like bacteriocins have to be elucidated to verify this new grouping.  
 
The structure of curvacin A may be obtained from the protein data bank (PDB) [129]. The PDB ID 
code is 2A2B.
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7 Appendix 
 
7.1 Equipments and chemicals 
 
Equipment:       Manufacturer: 
 
Wilmand NMR tubes (5mm)     Sigma-Aldrich 
UV-visible recording spectrophotometer (UV-160)   Shimadzu 
FPLC-system       Amersham Biosciences 
Resource RPC (3mL)      Amersham Biosciences 
Smart-system       Amersham Biosciences 
Avanti Centrifuge J-25      Beckman 
JA-14 Beckman rotor      Beckman 
Äkta purifier       Amersham Biosciences 
Voyager-DE RP mass spectrometer     Perseptive biosystems 
Biofuge pico       Heraeus instruments 
J-810 Spectropolarimeter      Jasco 
PCR-cycler       MJ Research 
Histag binding column      Novagene 
INOVA 800 NMR Spectrometer     Varian 
5 mm 1H {13C, 15N} pfg probe     Varian 
 
Chemicals: 
 
Sodium 2,2-dimetyl-2-silapentan-5-sulfonat (DSS)   Cambridge Isotope Lab. 
Deuterated dodecylphosphocholine (DPC) D38,9%   Cambridge Isotope Lab. 
Deuterium oxide 99,96%      Aldrich Chemical Company 
MRS Broth (CM 359)      Oxoid Ltd. 
Propanol       Merck 
NaCl        Merck 
NaH2PO4       Merck 
Na2HPO4       Merck 
Triflourethanol (TFE)      Aldrich/Merck 
Acetonitril       Merck 
α-cyano-4-hydroxycinnamic acid (CHCA)    Sigma 
Ethanol        Arcus 
Q Sepharose Fast Flow      Amersham Biosciences 
E. coil BL21(DE3)pLys S      Stratagene 
pET 3a-plasmid       Novagene 
Oglionucleotides       Eurogenetec 
Restriction enzymes      Fermentas 
Plasmid mini prep kit      QiAgene 
GFXTM DNA purification kit     Amersham Biosciences 
Mutagenesis kit       Stratagene 
IPTG        Fermentas 
Urea        Merck 
TrisCl        Merck 
DPC        CDN Isotopes 
D2O        Cambridge Isotope Laboratories 
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7.2 Resonance assignment of curvacin A 
 
RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
       
2 ARG+ HA 2 ARG+ QG 4.53 
2 ARG+ HA 2 ARG+ QB 3.93 
2 ARG+ HA 2 ARG+ QD 5.5 
2 ARG+ HN 2 ARG+ QB 3.75 
2 ARG+ HN 2 ARG+ QG 3.91 
2 ARG+ HN 2 ARG+ HA 4.52 
2 ARG+ QB 2 ARG+ HE 4.83 
2 ARG+ QB 2 ARG+ QD 3.75 
2 ARG+ QB 2 ARG+ QG 3.35 
2 ARG+ QD 2 ARG+ HE 3.94 
2 ARG+ QG 2 ARG+ HE 4.5 
2 ARG+ QG 2 ARG+ QD 3.77 
2 ARG+ HA 3 SER HN 3.64 
2 ARG+ HN 3 SER HN 4.77 
2 ARG+ QB 3 SER HN 4.9 
2 ARG+ QG 3 SER HN 4.49 
2 ARG+ QB 4 TYR QE 4.14 
2 ARG+ QB 4 TYR QD 5.24 
2 ARG+ QD 4 TYR QE 4.22 
2 ARG+ QG 4 TYR QE 3.2 
2 ARG+ QG 4 TYR HB2 5.5 
2 ARG+ QG 9 TYR QD 5.8 
2 ARG+ QG 9 TYR HB3 4.98 
2 ARG+ QG 9 TYR HA 4.59 
3 SER HA 3 SER HB3 4.66 
3 SER HA 3 SER HB2 4.91 
3 SER HB2 3 SER HB3 3.19 
3 SER HN 3 SER HB3 4.1 
3 SER HN 3 SER HB2 3.96 
3 SER HN 3 SER HA 4.6 
3 SER HA 4 TYR HN 3.6 
3 SER HB2 4 TYR HN 4.43 
3 SER HB3 4 TYR HN 4.43 
3 SER HN 4 TYR QD 4.71 
3 SER HN 4 TYR HN 3 
3 SER HN 8 VAL QG1 4.57 
3 SER HN 8 VAL QG2 4.19 
3 SER HA 9 TYR QD 5.11 
3 SER HA 9 TYR QE 5.5 
3 SER HB2 9 TYR QE 4.92 
3 SER HB2 9 TYR QD 5.5 
3 SER HB3 9 TYR QE 5.22 
3 SER HN 9 TYR QD 5.28 
4 TYR HB2 3 SER HN 4 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
4 TYR HA 4 TYR QD 5.16 
4 TYR HB2 4 TYR QD 3.76 
4 TYR HN 4 TYR HB2 3.88 
4 TYR HN 4 TYR HA 4.28 
4 TYR QD 4 TYR QE 2.98 
4 TYR HB2 8 VAL QG2 4.81 
4 TYR HB3 8 VAL QG2 4.82 
4 TYR HB3 8 VAL QG1 5.24 
4 TYR HB3 8 VAL HA 6 
4 TYR QD 8 VAL QG2 4.8 
4 TYR QD 8 VAL HB 6 
5 GLY HN 5 GLY QA 3.97 
6 ASN HA 6 ASN QB 4.91 
6 ASN HD21 6 ASN HD22 2.69 
6 ASN HN 6 ASN QB 3.42 
6 ASN QB 6 ASN HD22 3.7 
6 ASN QB 6 ASN HD21 3.87 
6 ASN QB 7 GLY HN 4.52 
7 GLY HA2 7 GLY HA1 3.89 
7 GLY HN 7 GLY HA2 3.5 
7 GLY HN 7 GLY HA1 3.6 
7 GLY HA1 8 VAL HN 4.19 
7 GLY HA2 8 VAL HN 4.28 
7 GLY HA2 8 VAL HB 5.5 
7 GLY HN 8 VAL HN 4.1 
7 GLY HN 8 VAL HB 4.8 
7 GLY HA1 9 TYR QE 5.41 
7 GLY HA2 9 TYR QE 5.58 
8 VAL QG1 4 TYR HN 5 
8 VAL HA 8 VAL QG1 3.89 
8 VAL HA 8 VAL QG2 3.69 
8 VAL HA 8 VAL HB 3.89 
8 VAL HB 8 VAL QG1 3.93 
8 VAL HB 8 VAL QG2 3.58 
8 VAL HN 8 VAL QG1 3.71 
8 VAL HN 8 VAL HB 3.82 
8 VAL HN 8 VAL QG2 4.3 
8 VAL HN 8 VAL HA 4.28 
8 VAL HB 9 TYR HN 3.66 
8 VAL HN 9 TYR HN 4.31 
8 VAL QG1 9 TYR HN 4.67 
8 VAL QG2 9 TYR HN 4.25 
9 TYR QE 7 GLY HN 4.8 
9 TYR QE 8 VAL QG2 5.9 
9 TYR HA 9 TYR QD 4.35 
9 TYR HA 9 TYR HB3 4.9 
9 TYR HN 9 TYR QE 4.53 
9 TYR HN 9 TYR QD 4.21 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
9 TYR HN 9 TYR HB3 3.51 
9 TYR HN 9 TYR HA 3.36 
9 TYR QD 9 TYR HB3 3.87 
9 TYR QE 9 TYR QD 2.96 
9 TYR QE 9 TYR HB3 4.51 
9 TYR QE 9 TYR HB2 4.53 
9 TYR HN 10 CYSS HN 3.62 
9 TYR QD 10 CYSS HN 4.89 
9 TYR QD 10 CYSS HB3 6 
9 TYR QD 16 TRP HE1 6 
10 CYSS HN 9 TYR HB3 6 
10 CYSS HN 10 CYSS HB2 4.21 
10 CYSS HN 10 CYSS HB3 4.5 
10 CYSS HB3 11 ASN HN 5.5 
10 CYSS HN 11 ASN HN 4.72 
11 ASN HA 11 ASN HB2 3.85 
11 ASN HA 11 ASN HB3 4.2 
11 ASN HB2 11 ASN HD21 4.47 
11 ASN HB2 11 ASN HD22 4.27 
11 ASN HB2 11 ASN HB3 2.81 
11 ASN HB3 11 ASN HD21 4.8 
11 ASN HB3 11 ASN HD22 3.61 
11 ASN HD21 11 ASN HD22 3 
11 ASN HN 11 ASN HB2 3.95 
11 ASN HN 11 ASN HB3 3.89 
11 ASN HN 11 ASN HA 3.96 
11 ASN HB2 12 ASN HD22 5.5 
11 ASN HB2 12 ASN HN 4.29 
11 ASN HB3 12 ASN HN 3.7 
11 ASN HD21 12 ASN HD22 4.55 
11 ASN HD21 12 ASN HB2 5.2 
11 ASN HB2 14 LYS+ QZ 5 
11 ASN HB3 14 LYS+ QZ 5.57 
11 ASN HD22 14 LYS+ QE 5 
11 ASN HN 14 LYS+ HN 5 
11 ASN HB2 16 TRP HH2 4.94 
11 ASN HB2 16 TRP HZ3 5 
11 ASN HB3 16 TRP HH2 5 
11 ASN HB3 16 TRP HZ3 5 
11 ASN HN 16 TRP HZ3 5 
12 ASN HB2 12 ASN HD21 3.95 
12 ASN HB2 12 ASN HB3 2.72 
12 ASN HB2 12 ASN HD22 4.14 
12 ASN HB3 12 ASN HD21 4.12 
12 ASN HB3 12 ASN HD22 4.29 
12 ASN HD22 12 ASN HD21 2.79 
12 ASN HN 12 ASN HB3 4.7 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
12 ASN HN 12 ASN HD21 4.23 
12 ASN HN 12 ASN HD22 5.38 
12 ASN HN 12 ASN HB2 3.78 
12 ASN HN 12 ASN HB3 4 
12 ASN HD21 13 LYS+ QZ 6 
12 ASN HB3 14 LYS+ HN 5.5 
12 ASN HD21 14 LYS+ QE 5.5 
12 ASN HN 14 LYS+ QZ 5 
13 LYS+ HA 13 LYS+ QB 3.31 
13 LYS+ HA 13 LYS+ HG2 3.9 
13 LYS+ HA 13 LYS+ QE 5.43 
13 LYS+ HA 13 LYS+ QD 6 
13 LYS+ HG2 13 LYS+ QE 4.5 
13 LYS+ HG2 13 LYS+ QD 3.24 
13 LYS+ HG3 13 LYS+ QE 4.91 
13 LYS+ HG3 13 LYS+ QD 3.27 
13 LYS+ HN 13 LYS+ HG2 4.73 
13 LYS+ HN 13 LYS+ HG3 5.24 
13 LYS+ HN 13 LYS+ HA 3.74 
13 LYS+ QB 13 LYS+ QD 3.9 
13 LYS+ QB 13 LYS+ HN 4 
13 LYS+ QB 13 LYS+ HG2 4 
13 LYS+ QD 13 LYS+ QE 3.53 
13 LYS+ QD 13 LYS+ QZ 5.1 
13 LYS+ QE 13 LYS+ QZ 3.93 
13 LYS+ QE 13 LYS+ QB 6 
13 LYS+ HA 14 LYS+ QG 5.7 
13 LYS+ HG2 14 LYS+ HN 4.36 
13 LYS+ HN 14 LYS+ HN 4.29 
13 LYS+ HN 14 LYS+ QB 5.5 
13 LYS+ HN 14 LYS+ QG 5.5 
13 LYS+ QB 14 LYS+ QZ 5.4 
13 LYS+ QB 14 LYS+ HN 3.87 
13 LYS+ QD 14 LYS+ QE 5.2 
13 LYS+ QD 14 LYS+ HN 3.82 
13 LYS+ QD 14 LYS+ HN 6 
13 LYS+ QE 14 LYS+ QB 5.36 
13 LYS+ QE 14 LYS+ QD 4.1 
13 LYS+ QE 14 LYS+ QG 4.9 
14 LYS+ QE 13 LYS+ QB 6 
14 LYS+ QG 13 LYS+ QB 4 
14 LYS+ QZ 13 LYS+ QB 6 
14 LYS+ HA 14 LYS+ QB 3.69 
14 LYS+ HA 14 LYS+ QG 4.55 
14 LYS+ HA 14 LYS+ QD 5.27 
14 LYS+ HN 14 LYS+ QB 3.61 
14 LYS+ HN 14 LYS+ QG 3.95 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
14 LYS+ HN 14 LYS+ HA 4.41 
14 LYS+ HN 14 LYS+ QE 6 
14 LYS+ QB 14 LYS+ QE 4.1 
14 LYS+ QB 14 LYS+ QD 3.29 
14 LYS+ QB 14 LYS+ QG 3.34 
14 LYS+ QB 14 LYS+ QZ 5.5 
14 LYS+ QD 14 LYS+ QE 3.7 
14 LYS+ QD 14 LYS+ QZ 5.5 
14 LYS+ QE 14 LYS+ QZ 4.76 
14 LYS+ QG 14 LYS+ QZ 4.43 
14 LYS+ QG 14 LYS+ QD 3.16 
14 LYS+ QG 14 LYS+ QE 4.63 
14 LYS+ HA 15 CYSS HN 4.7 
14 LYS+ QB 15 CYSS HB2 5.5 
14 LYS+ QB 15 CYSS HB3 5.5 
14 LYS+ QB 15 CYSS HN 3.83 
14 LYS+ QE 15 CYSS HN 4.27 
14 LYS+ QG 15 CYSS HN 4.33 
14 LYS+ QZ 15 CYSS HN 5.15 
14 LYS+ QB 16 TRP HN 5.2 
15 CYSS HN 11 ASN HB2 6 
15 CYSS HA 15 CYSS HB3 5.12 
15 CYSS HN 15 CYSS HB2 3.94 
15 CYSS HN 15 CYSS HB3 3.97 
16 TRP HA 16 TRP QB 4.44 
16 TRP HA 16 TRP HE3 5.5 
16 TRP HA 16 TRP HD1 5 
16 TRP HD1 16 TRP HE1 3.68 
16 TRP HE1 16 TRP HH2 5.47 
16 TRP HE3 16 TRP HH2 4.47 
16 TRP HE3 16 TRP HZ3 3.46 
16 TRP HE3 16 TRP HD1 5.2 
16 TRP HE3 16 TRP HN 5.8 
16 TRP HH2 16 TRP HZ2 3.42 
16 TRP HH2 16 TRP HZ3 3.4 
16 TRP HN 16 TRP HD1 5.5 
16 TRP HN 16 TRP QB 3.72 
16 TRP HN 16 TRP HA 3.72 
16 TRP HZ2 16 TRP HD1 5.6 
16 TRP HZ2 16 TRP HE1 4.21 
16 TRP HZ3 16 TRP HZ2 4.32 
16 TRP QB 16 TRP HE3 3.68 
16 TRP QB 16 TRP HD1 3.82 
16 TRP QB 16 TRP HZ3 5.23 
16 TRP HA 17 VAL QG1 6 
16 TRP HA 17 VAL QG2 6 
16 TRP HD1 17 VAL QG1 5.5 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
16 TRP HN 17 VAL QG1 4.64 
16 TRP QB 17 VAL QG1 4.87 
16 TRP QB 17 VAL QG2 6 
16 TRP HD1 19 ARG+ HB2 6 
17 VAL HA 17 VAL QG1 3.41 
17 VAL HA 17 VAL HB 3.66 
17 VAL HA 17 VAL QG2 4 
17 VAL HN 17 VAL QG1 5 
17 VAL QG1 17 VAL HB 2.98 
17 VAL HB 18 ASN HN 5.5 
17 VAL QG1 18 ASN HN 4.24 
17 VAL QG1 18 ASN HB2 4.83 
17 VAL QG2 18 ASN HB2 5.2 
18 ASN HB2 18 ASN HD21 3.77 
18 ASN HB3 18 ASN HD22 5.5 
18 ASN HB3 18 ASN HD21 4.5 
18 ASN HB3 18 ASN HB2 2.94 
18 ASN HD22 18 ASN HD21 2.82 
18 ASN HN 18 ASN HB3 4.19 
18 ASN HN 18 ASN HB2 3.73 
18 ASN HN 18 ASN HB3 4 
19 ARG+ QD 6 ASN HD22 5 
19 ARG+ QH1 6 ASN HD22 5 
19 ARG+ QD 16 TRP HZ3 6 
19 ARG+ HA 19 ARG+ HB2 3.36 
19 ARG+ HA 19 ARG+ QG 3.98 
19 ARG+ HA 19 ARG+ HB3 5.6 
19 ARG+ HA 19 ARG+ QD 5.26 
19 ARG+ HA 19 ARG+ HE 4.96 
19 ARG+ HB2 19 ARG+ HE 4.24 
19 ARG+ HB2 19 ARG+ QG 3.18 
19 ARG+ HB3 19 ARG+ HE 4.23 
19 ARG+ HB3 19 ARG+ QD 4.32 
19 ARG+ HN 19 ARG+ QD 5.5 
19 ARG+ HN 19 ARG+ HA 3.91 
19 ARG+ HN 19 ARG+ HB3 4.9 
19 ARG+ HN 19 ARG+ HB2 3.52 
19 ARG+ HN 19 ARG+ QG 4.1 
19 ARG+ QD 19 ARG+ HE 3.9 
19 ARG+ QD 19 ARG+ QG 4.4 
19 ARG+ QD 19 ARG+ HB2 4.71 
19 ARG+ QD 19 ARG+ HB2 3.97 
19 ARG+ QD 19 ARG+ HB3 4.1 
19 ARG+ QG 19 ARG+ HE 4.2 
19 ARG+ QG 19 ARG+ QD 4.62 
19 ARG+ HA 20 GLY HN 4.36 
19 ARG+ HB2 20 GLY QA 5.5 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
19 ARG+ HN 20 GLY HN 4.33 
19 ARG+ QG 20 GLY HN 5.24 
19 ARG+ HA 22 ALA QB 6 
20 GLY HN 20 GLY QA 3.4 
20 GLY HN 21 GLU HN 4.36 
20 GLY QA 21 GLU HN 3.72 
21 GLU HA 21 GLU HG2 4.25 
21 GLU HA 21 GLU HG3 4.2 
21 GLU HA 21 GLU HB2 4.31 
21 GLU HA 21 GLU HB3 4.38 
21 GLU HB2 21 GLU HG3 4.33 
21 GLU HB2 21 GLU HG2 4.49 
21 GLU HB3 21 GLU HG2 3.99 
21 GLU HB3 21 GLU HG3 4.33 
21 GLU HG2 21 GLU HG3 3.35 
21 GLU HN 21 GLU HB3 3.58 
21 GLU HN 21 GLU HB2 3.54 
21 GLU HN 21 GLU HG2 6 
21 GLU HN 21 GLU HG3 6 
21 GLU HB3 22 ALA HN 4.27 
21 GLU HG3 22 ALA HN 5.5 
21 GLU HG3 22 ALA QB 5.5 
21 GLU HA 24 GLN HN 5.5 
22 ALA HA 22 ALA QB 3.42 
22 ALA HN 22 ALA HA 3.91 
22 ALA HN 22 ALA QB 3.41 
22 ALA HN 23 THR HN 3.72 
22 ALA QB 23 THR HB 4.18 
22 ALA QB 23 THR HN 3.77 
22 ALA QB 24 GLN QG 5.42 
23 THR HA 23 THR QG2 3.49 
23 THR HA 23 THR HB 4.99 
23 THR HN 23 THR HA 4.9 
23 THR HN 23 THR HB 3.65 
23 THR HA 24 GLN HN 4.54 
23 THR HN 24 GLN HN 3.71 
23 THR HN 24 GLN QG 4.2 
23 THR QG2 24 GLN HN 5.18 
24 GLN HN 22 ALA QB 5 
24 GLN HA 24 GLN QG 3.88 
24 GLN HA 24 GLN HB3 3.86 
24 GLN HA 24 GLN HB2 3.95 
24 GLN HB2 24 GLN QG 3.75 
24 GLN HB2 24 GLN HB3 3.25 
24 GLN HB3 24 GLN QG 3.83 
24 GLN HE22 24 GLN HE21 3.12 
24 GLN HN 24 GLN HB2 4 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
24 GLN HN 24 GLN HA 3.61 
24 GLN HN 24 GLN HB3 3.65 
24 GLN HN 24 GLN QG 4.5 
24 GLN QG 24 GLN HE21 4.32 
24 GLN QG 24 GLN HE22 4.62 
24 GLN HB2 25 SER HN 6 
24 GLN HB3 25 SER HN 6 
25 SER HA 25 SER HB3 4.45 
25 SER HA 25 SER HB2 5 
25 SER HB2 25 SER HB3 3.3 
25 SER HN 25 SER HB3 3.69 
25 SER HN 25 SER HA 4.14 
25 SER HB2 26 ILE QG1 6 
25 SER HB3 26 ILE HN 4.2 
25 SER HB3 27 ILE HN 3.98 
26 ILE QG2 25 SER HB3 5.58 
26 ILE HA 26 ILE QD1 4 
26 ILE HA 26 ILE HB 3.78 
26 ILE HA 26 ILE QG2 5.32 
26 ILE HB 26 ILE QG1 3.87 
26 ILE HB 26 ILE QD1 3.92 
26 ILE HN 26 ILE QG2 4.37 
26 ILE HN 26 ILE QD1 4.42 
26 ILE HN 26 ILE HA 3.69 
26 ILE HN 26 ILE QG1 4.17 
26 ILE HN 26 ILE HB 3.61 
26 ILE HA 27 ILE HN 5.5 
26 ILE HB 27 ILE HN 3.86 
26 ILE QG1 27 ILE HN 6 
26 ILE QG2 27 ILE HN 4.24 
26 ILE QG2 27 ILE HA 5.46 
26 ILE QG2 27 ILE QG2 6 
27 ILE HA 27 ILE QG1 4.35 
27 ILE HA 27 ILE HB 4.4 
27 ILE HA 27 ILE QG2 3.6 
27 ILE HB 27 ILE QD1 3.65 
27 ILE HB 27 ILE QG1 3.6 
27 ILE HN 27 ILE HB 3.43 
27 ILE HN 27 ILE HA 3.63 
27 ILE HN 27 ILE QD1 3.87 
27 ILE HN 27 ILE QG2 3.66 
27 ILE HN 27 ILE QG1 3.9 
27 ILE QG2 27 ILE QG1 3.14 
27 ILE QG2 27 ILE HB 3.8 
27 ILE HN 28 GLY HN 3.73 
28 GLY HA1 28 GLY HA2 3.97 
28 GLY HN 28 GLY HA2 3.76 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
28 GLY HN 28 GLY HA1 3.6 
28 GLY HA2 29 GLY HN 4.46 
28 GLY HN 29 GLY HN 4.11 
28 GLY HN 30 MET HN 6 
29 GLY HA1 29 GLY HA2 3.28 
29 GLY HN 29 GLY HA2 4.8 
29 GLY HN 29 GLY HA1 3.19 
29 GLY HN 30 MET HN 4.9 
30 MET HB2 27 ILE HA  
30 MET HA 30 MET HG2 4.29 
30 MET HA 30 MET HG3 3.99 
30 MET HA 30 MET HB2 3.9 
30 MET HA 30 MET HB3 3.54 
30 MET HB2 30 MET HG2 3.86 
30 MET HB2 30 MET HG3 3.67 
30 MET HB3 30 MET HG3 3.92 
30 MET HB3 30 MET HB2 3.16 
30 MET HB3 30 MET HG2 4.2 
30 MET HG2 30 MET HG3 3.14 
30 MET HN 30 MET HA 3.91 
30 MET HN 30 MET HB3 3.92 
30 MET HN 30 MET HB2 3.81 
30 MET HN 30 MET HG2 4.16 
30 MET HN 30 MET HG3 4.43 
30 MET HA 31 ILE HN 4.22 
30 MET HB2 31 ILE HA 4.59 
30 MET HB2 31 ILE HN 4.36 
30 MET HB3 31 ILE HN 4.3 
30 MET HG2 31 ILE HN 5.12 
30 MET HG3 31 ILE HN 5.49 
30 MET HN 31 ILE HN 3.56 
31 ILE HA 31 ILE QG1 3.34 
31 ILE HA 31 ILE HB 3.84 
31 ILE HA 31 ILE QD1 4 
31 ILE HB 31 ILE QG1 3.2 
31 ILE HN 31 ILE QD1 4.51 
31 ILE HN 31 ILE HA 4.21 
31 ILE HN 31 ILE HB 4.9 
31 ILE HN 31 ILE QG2 3.84 
31 ILE HN 31 ILE QG1 4.2 
31 ILE QG2 31 ILE QG1 3.14 
31 ILE QG2 31 ILE HB 4.14 
31 ILE QG2 31 ILE QD1 2.65 
31 ILE HA 32 SER HN 4.36 
31 ILE HB 32 SER HN 4 
31 ILE HN 32 SER HN 3.65 
31 ILE QD1 32 SER HN 4.16 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
31 ILE QG1 32 SER HN 3.41 
31 ILE QG1 32 SER HA 3.91 
31 ILE QG2 32 SER HB3 5.1 
31 ILE QG2 32 SER HA 3.58 
31 ILE QG2 32 SER HN 4.19 
31 ILE HB 33 GLY HN 6 
31 ILE HA 34 TRP HB2 5.2 
31 ILE HA 34 TRP HE3 4.4 
31 ILE HA 34 TRP HB3 4.39 
31 ILE HA 34 TRP HN 3.95 
31 ILE HA 34 TRP HD1 6 
31 ILE QG1 34 TRP HE3 4.72 
31 ILE QG1 34 TRP HN 6 
31 ILE QG2 34 TRP HE3 5.5 
31 ILE HA 35 ALA QB 6 
31 ILE QG1 35 ALA HN 4.75 
32 SER HA 32 SER HB2 5.19 
32 SER HA 32 SER HB3 6 
32 SER HA 32 SER HB3 4 
32 SER HN 32 SER HA 3.35 
32 SER HN 32 SER HB3 3.7 
32 SER HN 34 TRP HN 5 
32 SER HA 35 ALA HN 5.2 
32 SER HA 35 ALA QB 5.5 
32 SER HA 36 SER HN 5.5 
33 GLY HN 30 MET HB3 5.8 
33 GLY HN 33 GLY QA 4.26 
33 GLY HN 34 TRP HN 3.78 
33 GLY HN 35 ALA HN 5.5 
34 TRP HA 34 TRP HD1 4.62 
34 TRP HB2 34 TRP HD1 4.57 
34 TRP HB2 34 TRP HE3 4.35 
34 TRP HB3 34 TRP HD1 4.34 
34 TRP HB3 34 TRP HE3 3.86 
34 TRP HB3 34 TRP HZ3 5.5 
34 TRP HE1 34 TRP HD1 3.82 
34 TRP HE3 34 TRP HD1 5.16 
34 TRP HE3 34 TRP HH2 5.2 
34 TRP HE3 34 TRP HZ3 3.37 
34 TRP HH2 34 TRP HZ3 3.3 
34 TRP HN 34 TRP HD1 4.67 
34 TRP HN 34 TRP HB3 3.83 
34 TRP HN 34 TRP HB2 3.75 
34 TRP HN 34 TRP HA 4.41 
34 TRP HN 34 TRP HD1 6 
34 TRP HN 34 TRP HE3 6 
34 TRP HZ2 34 TRP HD1 5.4 
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RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
34 TRP HZ2 34 TRP HH2 3.44 
34 TRP HZ2 34 TRP HE1 4.42 
34 TRP HZ3 34 TRP HZ2 4.28 
34 TRP HB2 35 ALA HN 4.46 
34 TRP HB2 35 ALA QB 5.17 
34 TRP HB3 35 ALA QB 5.18 
34 TRP HB3 35 ALA HN 4.22 
34 TRP HD1 35 ALA HN 6 
34 TRP HE3 35 ALA HA 4.7 
34 TRP HE3 35 ALA HN 4.73 
34 TRP HE3 35 ALA QB 4.8 
34 TRP HN 35 ALA HN 3.81 
34 TRP HZ3 35 ALA QB 5.35 
34 TRP HB3 36 SER HN 4.87 
34 TRP HN 36 SER HN 3.84 
34 TRP HE3 38 LEU QQD 5.2 
34 TRP HZ3 38 LEU QQD 5.12 
35 ALA HA 35 ALA QB 3.29 
35 ALA HN 35 ALA QB 3.55 
35 ALA HN 35 ALA HA 4.11 
35 ALA HA 36 SER HN 3.62 
35 ALA HN 36 SER HN 4.6 
35 ALA QB 36 SER HN 3.84 
35 ALA HA 37 GLY HN 4.53 
35 ALA QB 37 GLY HN 4.5 
35 ALA HA 38 LEU HB2 5.5 
35 ALA HA 39 ALA HN 5.5 
36 SER HA 36 SER QB 4.4 
36 SER HN 36 SER HA 3.9 
36 SER HN 36 SER QB 3.56 
36 SER HA 37 GLY HN 4.59 
36 SER HN 37 GLY HN 3.45 
36 SER HN 38 LEU HN 4.55 
37 GLY HA1 37 GLY HA2 2.91 
37 GLY HN 37 GLY HA2 3.75 
37 GLY HN 37 GLY HA1 3.46 
37 GLY HA1 38 LEU HN 4.3 
37 GLY HA2 38 LEU HN 3.92 
37 GLY HN 38 LEU HG 5.29 
37 GLY HN 38 LEU HN 3.81 
37 GLY HN 38 LEU QQD 4.36 
37 GLY HA1 40 GLY HN 5.5 
37 GLY HA2 40 GLY HN 5.5 
38 LEU HB3 35 ALA HA 5.5 
38 LEU HA 38 LEU QQD 3.41 
38 LEU HA 38 LEU HB2 4.16 
38 LEU HA 38 LEU HG 3.72 
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RESIDUE 
1   
RESIDUE 
2  DISTANCE
RESIDUENUMBER RESIDUE MOLECULE RESIDUENUMBER RESIDUE MOLECULE  
 
38 LEU HB2 38 LEU QQD 3.39 
38 LEU HB3 38 LEU HN 3.61 
38 LEU HG 38 LEU QQD 3.15 
38 LEU HG 38 LEU HB2 2.92 
38 LEU HN 38 LEU HB2 3.71 
38 LEU HN 38 LEU HA 4.8 
38 LEU HN 38 LEU HG 3.89 
38 LEU HN 38 LEU QQD 3.88 
38 LEU HG 40 GLY HN 5.5 
38 LEU HN 40 GLY HN 5.5 
39 ALA HA 39 ALA QB 3.84 
39 ALA HN 39 ALA QB 3.49 
39 ALA HN 39 ALA HA 3.93 
39 ALA HA 40 GLY HN 4.26 
39 ALA HN 40 GLY HN 4.42 
39 ALA QB 40 GLY HA1 3.87 
39 ALA QB 40 GLY HN 3.91 
39 ALA HA 41 MET HN 4.53 
39 ALA QB 41 MET HN 4.49 
40 GLY HN 38 LEU QQD 6 
40 GLY HN 40 GLY HA1 3.3 
40 GLY HA1 41 MET HN 4.54 
40 GLY HA1 41 MET QB 4.45 
40 GLY HA2 41 MET HN 4.16 
40 GLY HN 41 MET HN 3.95 
41 MET HA 41 MET QB 3.78 
41 MET HA 41 MET HG3 5.25 
41 MET HG2 41 MET HG3 2.93 
41 MET HN 41 MET QB 3.61 
41 MET HN 41 MET HA 4.49 
41 MET HN 41 MET HG3 4.62 
41 MET HN 41 MET HG2 4.58 
41 MET QB 41 MET HG2 4.4 
 
 
